Histopathological Spectrum of  Ovarian Tumors – A Descriptive Study. by Darshana, S Patil
HISTOPATHOLOGICAL SPECTRUM OF OVARIAN TUMORS:  
 
                                   A DESCRIPTIVE STUDY 
 
             
                         
 
 
Dissertation submitted in 
Partial fulfillment of the regulations required for the award of 
M.D. DEGREE 
IN 
PATHOLOGY 
 
THE TAMILNADU 
DR.M.G.R. MEDICAL UNIVERSITY, 
CHENNAI                                         
   MARCH    2011 
  
CERTIFICATE 
 
 
This is to certify that the dissertation entitled “Histopathological 
spectrum of ovarian tumors – A descriptive study” is a record of   
bonafide work done by Dr. Darshana S. Patil in the Department of 
Pathology, Coimbatore Medical College, Coimbatore and submitted in 
partial fulfillment of the requirements for the award of M.D. Degree in 
Pathology by the Tamilnadu Dr. MGR University, Chennai. This work 
has not previously formed the basis for the award of a degree or diploma. 
 
 
            
 
 
 Dr. M. Murthy, M.D.                                              Dr. R.Vimala, M.D. 
 
 Professor and Head,                                                                          Dean, 
 
 Department of Pathology,                           Coimbatore Medical College, 
 
 Coimbatore Medical College,                                          Coimbatore - 14.  
 
 Coimbatore - 14. 
 
                                                 
 
ACKNOWLEDGEMENT 
 
 
I express my deep gratitude to Dr. R.Vimala M.D. Dean, 
Coimbatore Medical College, for granting me permission to undertake 
this study. 
With an immense sense of gratitude, I humbly thank                    
Dr. M.Murthy, M.D. Professor and Head, Department of Pathology, 
Coimbatore Medical College, for his scholarly guidance, advice and for 
having rendered his valuable time and encouragement, without which this 
study would not have been feasible.  
I express my heartfelt thanks to all Additional Professors and all 
Assistant Professors of Department of Pathology, Coimbatore Medical 
College, for their constant support and encouragement throughout the 
work. I thank all the technical staff of Department of Pathology, 
Coimbatore Medical College, for their sincere and timely technical 
assistance. 
I thank my family members for their blessings and moral support. 
Above all I thank The almighty for all his blessings. 
CONTENTS 
 
SR.NO.   PARTICULARS    PAGE NO. 
 
 
    1.    INTRODUCTION     1 
  
    2.    AIMS AND OBJECTIVES     4 
    
    3.    NEED FOR THE STUDY    5 
  
    4.    REVIEW OF LITERATURE     6 
  
    5.    MATERIAL AND METHODS   36 
  
    6.    OBSERVATION AND RESULTS   39 
  
    7.    DISCUSSION      55 
    
    8.    SUMMARY AND CONCLUSION   67 
  
    9.    BIBLIOGRAPHY 
  
   10.    ANNEXURES 
              
Annexure I   - Proforma 
Annexure II  - H & E Stain procedure 
Annexure III - PAS Stain procedure 
Annexure IV - Reticulin Stain Procedure                             
Annexure V  - Immunohistochemistry Procedure 
Annexure VI - Master chart 
 1
                               INTRODUCTION 
 
 
Ovarian cancer is the fifth most common malignancy among 
women and second most common gynecologic malignancy. It is the most 
common cause of death due to malignancy of female genital tract.1 
Ovarian  malignancies constitute about 4% of the total cancers in females 
and 25% of malignant tumors of the female genital tract.2 In India, the 
ovary is next in importance to cervix as the seat of cancer of female 
genital tract. Surface epithelial ovarian tumors constitute two thirds of all  
ovarian tumors and malignant forms account for 90% of ovarian cancers.3  
They exist in different histological patterns and exhibit varying degree of  
aggressiveness.4      
           Ovary is subjected to monthly endocrine and traumatic insults 
during normal ovulatory cycles and becomes susceptible to 
tumorogenesis. Repeated ovulatory rupture and repair theoretically 
creates opportunities for malignant gene mutations. This may explain the 
apparent protective effects of oral contraceptives, late menarche, early 
menopause, multiparity, and breast feeding. Each of these factors 
decrease the occurrence of ovulation.5 Although no age group is free 
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from the tumors, different tumors tend to involve different age groups 
preferentially. The complex anatomy of the ovary and its peculiar 
physiology with the constant cyclical changes from puberty to 
menopause give rise to number of cell types, each of which is capable of 
giving rise to tumors. Both primary and secondary tumors of the ovaries 
are relatively frequent showing a variety of histopathological patterns.6 
Since germ cells are totipotential, it is not surprising that a very  wide 
variety of neoplasms may develop from them. Germ cell tumors are the 
commonest ovarian neoplasms in young age group and constitute two 
thirds of ovarian tumors in this age group, out of which one third are 
malignant. These tumors account for 25-30% of all ovarian tumors, with 
great majority of them in the category of mature cystic teratoma, the most 
common variety of ovarian neoplasm in humans.3 Ovarian tumors in 
children and adolescent girls constitute an important part of 
gynecological oncology. Detection of these tumors at such a young age 
creates much anxiety to parents and throws up a great challenge to 
doctors in charge as the question of operative safety, chance of 
malignancy and prospects of future child bearing associated with 
treatment. Practice of fertility sparing surgery, replacement of 
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radiotherapy by chemotherapy and arrival of newer chemotherapeutic 
drugs has made the prognosis much better today. The main aim lies in 
distinguishing ovarian neoplasms from the wide spectrum of non-
neoplastic lesions. Despite the new techniques in imaging and clinical 
diagnosis, the diagnosis of ovarian tumors is primarily dependent upon 
histopathological examination. 
 
Determination of various histologic patterns of ovarian tumors is  
very important in diagnosis as well as prognosis of ovarian tumors.  
Prognosis of the tumors can also be predicted from the degree of 
differentiation of the tumors. The stage and laterality of the tumors also 
indicates their nature for example, tumors in the sex cord stromal 
category are almost always confined to a single ovary. On the other hand,  
approximately 65% of the metastatic tumors are bilateral. In this study, it 
was aimed to find out the histopathological patterns which are more 
prevalent in our population and whether they are significantly different 
from other populations.7 Their characteristics with regard to age, size, 
laterality, gross features were evaluated. Incidence of benign versus 
malignant tumors was also studied. 
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                            AIMS AND OBJECTIVES 
 
 
 
 
1. To evaluate the incidence of different histopathological subtypes of  
 
      ovarian tumors in and around Coimbatore district. 
 
2. To study the incidence of malignancy, both primary and secondary 
 
in ovarian tumors            
 
3. To study the distribution of ovarian tumors with respect to various 
  
parameters like age, clinical presentation, parity, menstural  
 
     status, bilaterality, size, gross features and constistency of the tumors. 
 
4. To study the gross morphological patterns of the various  
 
histopathological tumor types. 
 
5. To evaluate the association between various parameters of ovarian  
tumors and risk of malignancy. 
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NEED FOR THE STUDY 
 
 
Ovarian tumors pose a major threat to public health worldwide. In 
global terms, ovarian cancer is the fifth most common cancer in females. 
Two thirds of ovarian tumors occur in reproductive age group. It has 
been estimated that one woman in 70 (1.4%) will develop ovarian cancer 
at some point during her lifetime. Its lower cure rates (less than 40%) 
result in 6% of total deaths in females. 
Thus studying the histopathological spectrum of the ovarian 
tumors will help to understand the relative incidence of malignancy over 
benign, distribution of different tumors according to age. Studying the 
correlation of tumors with various parameters like age at menarche, 
menstrual status and parity can help to understand the risk factors and 
pathogenesis of ovarian tumors. This study can also contribute to 
understand the correlation of gross morphological features with 
histopathological diagnosis which can certainly help us to arrive at a 
close differential diagnosis even only with gross examination alone in 
future. 
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REVIEW OF LITERATURE 
 
                     
Ovarian neoplasms have become increasingly important not only 
because of the large variety of neoplastic entities but more because they 
have gradually increased the mortality rate in female genital tract 
cancers.8 As proposed by Kurman et al, efforts at early detection and new 
therapeutic approaches to reduce mortality have been largely 
unsuccessful, because the origin and pathogenesis of ovarian cancer is 
poorly understood.9 
Embryological development of the ovary: 
  As emphasized by Harold N et al  in his study, in order to 
understand the broad range of ovarian tumors and the clinical 
significance of each tumor, we must review embryological origins of 
various histological subtypes.10 The developing ovary contains three 
types of cell, the oocytes, the follicular cells and the supporting stromal 
cells. 
Oocytes are derivatives of primordial germ cells that can result in 
germ cell tumors and represent the most common benign or malignant 
pediatric ovarian masses. Follicular cells are epithelial in origin and are 
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important in regulation of estrogen production and maturation of 
follicles. These cells give rise to epithelial tumors which are the 
commonest adult ovarian tumors. The stromal granulosa and theca cells 
are mesenchymal in origin. They surround follicular cells, support their 
development and are the origin of ovarian stromal tumors.  
Anatomy of the ovary: 
 
Ovaries are situated one on each side of uterus close to lateral 
pelvic wall.11 Each adult ovary measures 3-4 cm in length, 1.5- 3cm in 
width; 0.6-1.5cm in thickness .The average weight is 5-8 gms. 
 
Histology: 
 
The surface of the ovary is covered by a single layer of cuboidal 
cells, which forms germinal epithelium that is continuous with the 
mesothelial covering. Beneath the epithelium a tough connective tissue of  
tunica albuginea is present under which lies the thicker outer cortex and  
the inner medulla. Cortex shows follicles at varying stages of maturation. 
Classification: 
 
The primary purpose of classification of ovarian tumors is to 
implement a multidisciplinary approach in management of the patients 
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affected by ovarian carcinoma. As proposed by Langley F.A et al, the 
classification of ovarian tumors is primarily morphologic but is intended 
to reflect current concepts of embryogenesis and histogenesis of this 
complex organ.11,12 In 1973 World health organization (WHO) gave 
classification based  primarily on gross features. In late 1980, the 
International Society of Gynecological Pathologists gave a new  
Classification, which is adopted, as WHO CLASSIFICATION: 
 I. SURFACE EPITHELIAL – STROMAL TUMOURS 
 
A. SEROUS TUMOURS 
 
              1. Benign 
 
                              a. Cystadenoma and papillary cystadenoma 
 
                              b. Surface papilloma 
 
                              c. Adenofibroma and cystadenofibroma. 
 
              2. Of borderline malignancy  
 
                              a. Cystadenoma and papillary cystadenoma 
 
b. Surface papilloma 
 
c. Adenofibroma and cystadenofibroma 
 
  3. Malignant 
 
a. Papillary cystadenocarcinoma 
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b. Surface papillary carcinoma 
c. Malignant adenofibroma and cystadenofibroma. 
 
B. MUCINOUS TUMOURS 
 
Same as for serous tumors except that surface forms are exceptional. 
 
C. ENDOMETRIOD TUMOURS 
 
  1. Same as for serous tumors except that surface forms are rare. 
 
            2. Stromal and mixed epithelial stromal tumors 
 
a. Adenosarcoma 
 
b. Stromal sarcoma 
 
a. Mesodermal (Mullerian) mixed tumours  
 
D. CLEAR CELL TUMOURS 
 
    Same as for serous tumors except that surface forms are not reported. 
 
E. TRANSITIONAL CELL TUMORS 
 
1. Brenner tumor 
 
2. Of borderline malignancy (proliferating) 
 
3. Malignant 
 
4. Transitional cell carcinoma (non Brenner type) 
 
G. MIXED EPITHELIAL TUMOURS 
 
1. Benign 
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2. Of borderline malignancy 
 
3. Malignant 
 
H. UNDIFFERENTIATED CARCINOMA 
 
I.   UNCLASSIFIED 
  
 
II. SEX CORD-STROMAL TUMOURS 
 
A. GRANULOSA-STROMAL CELL TUMOURS 
 
        1. Granulosa cell tumour 
                               
                               a. Adult  
 
b. Juvenile 
 
2. Tumors in the thecoma-fibroma group 
 
a. Thecoma 
 
i) Typical 
 
ii) Luteinized 
 
b. Fibroma 
 
c. Fibrosarcoma 
 
d. Stromal tumor 
 
e. Sclerosing stromal tumor 
 
f. Signet cell stromal tumor 
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g. Unclassified 
 
 
B. SERTOLI-STROMAL CELL TUMOURS: 
 
1. Well differentiated 
 
       a. Sertoli cell tumour; tubular androblastoma  
 
b. Sertoli-Leydig cell tumour  
 
c. Leydig cell tumour / hilus cell tumour 
 
d. Stromal Leydig cell tumour 
 
2. Of intermediate differentiation  
3. Poorly differentiated [sarcomatioid] 
4. Retiform 
5. With heterologous elements 
6. Mixed 
C. SEX CORD TUMOURS WITH ANNULAR TUBULES 
 
D. GYNANDROBLASTOMA 
 
E. UNCLASSIFIED 
 
F. STEROID [LIPID] CELL TUMUORS 
 
1. Stromal luteoma 
 
2. Leydig cell tumor 
 
                    a. Hilus cell tumor 
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                    b. Leydig cell tumor non hilar type 
 
3. Adrenal cortical type 
 
4. Not otherwise specified 
 
 
III. GERM CELL TUMOURS 
 
A. DYSGERMINOMA 
 
B. YOLK SAC TUMOURS 
 
C. EMBRYONAL CARCINOMA 
 
D. POLYEMBRYOMA 
 
E. CHORIOCARCINOMA 
 
F. TERATOMAS 
 
1. Immature 
 
2. Mature 
a. Solid 
 
b. Cystic (Dermoid cyst) 
 
   c. Secondary tumors transformation of a component 
 
d. Fetiform (homunculus) 
 
2. Monodermal and highly specialized 
 
a. Struma ovarii 
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b. Carcinoid 
 
c. Strumal carcinoid 
d. Mucinous carcinoid 
 
e. Neuroectodermal tumors 
 
f. Others 
 
 
G. MIXED GERM CELL TUMORS 
 
IV. GONADOBLASTOMA 
 
1. Pure 
 
2. Mixed with dysgerminoma or other form of germ cell tumor 
 
V. GERM CELL- SEX CORD- STROMAL TUMORS 
 
VI. TUMOURS OF RETE OVARII 
 
1. Adenoma and cystadenoma 
 
2. Carcinoma 
 
VII.MESOTHELIAL TUMORS 
 
VIII. TUMOURS OF UNCERTAIN ORIGIN 
 
1. Small cell carcinoma hypercalcemic type 
 
2. Tumor of wolffian origin 
 
3. Hepatoid carcinoma 
 
4. Paraganglioma 
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5. Wilms tumor 
 
IX. SOFT TISSUE TUMOURS NOT SPECIFIC TO OVARY 
 
X. UNCLASSIFIED TUMOURS 
 
XI. SECONDARY [ METASTATIC ] TUMOURS 
 
 
I.SURFACE EPITHELIAL – STROMAL TUMORS: 
 
  As seen in study by Ramesh  Dawar et al (2004) this category 
constitutes almost two thirds of all ovarian tumors. 90% of all ovarian 
cancers are surface epithelial carcinomas.13 
They are subclassified according to following patterns: 
 
1) Cell type: serous / mucinous / endometroid / clear / transitional  
 
2) Exophytic / Intracystic 
 
          3)  Pattern of growth: cystic /solid 
 
          4) Amount of epithelium / stroma (adenoma / adenofibroma) 
 
5) Cell proliferation, nuclear atypia and stromal invasion: 
   
                               Benign / borderline / malignant. 
 
A. SEROUS TUMORS: 
 
These tumors comprise 30-40 % of all ovarian tumors and are 
common in 4-5th decade of life. Among these, as seen in study by Mario 
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M. Leitao et al, 70% are benign, 5-10% are borderline and 20-25% are 
malignant.14 Bilaterality is present in 12-20% cases. 
 
 1) Benign serous tumors: 
  
Grossly these are usually endophytic cystadenomas but may be 
exophytic surface papillomas. Grossly, they are unilocular thin walled 
cysts filled with serous fluid with smooth inner surface. Multiloculation, 
mucinous contents and polypoid excrescence may also be seen. 
Microscopic examination reveals fallopian tube like epithelial lining. 
Stroma may be collagenous or markedly edematous. In 
cystadenofibromas, glands and cysts are scattered within predominantly 
fibrous stroma.  
2) Serous borderline ovarian tumors: 
 
They constitute 25-30% of malignant serous tumors with 30% 
bilaterality. The decision whether an ovarian serous tumor is malignant 
or borderline is made purely on the basis of morphologic features of 
primary ovarian tumor regardless of presence or absence of peritoneal, 
lymph node or even lung metastasis.15,16 These tumors are separated from  
carcinoma by the absence of stromal invasion. These tumors are 
composed of uni/multilocular cysts lined by varying amount of polypoid 
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excrescences. Microscopy shows stratified cuboidal to columnar pithelial 
cells and ciliated cells. As revealed by Seidman JD et al, arborizing 
papillae / hierarchical branching, varying nuclear atypia and absence of 
frank stromal invasion characterize them.17  
Micropapillary Variant: 
 
Histologically it is characterized by an exuberant cellular proliferation 
that emanates from the surfaces of fibrous papillae without hierarchical  
branching.18,19  
Peritoneal implants: 
The serous borderline tumors are associated with implants in 30% 
of cases. These are divided into non-invasive and invasive types. Non 
invasive which constitute 88% of all, are further subdivided into 
epithelial and desmoplastic types. 
3) Malignant serous tumors:  
 
Serous carcinomas account for about 30 % of all ovarian cancers. These 
range in size from microscopically undetectable to over 20 cm in 
diameter and are bilateral in one third of cases as seen in study done by 
CM Shahbaz Sarwar et al.20 Grossly they show predominant solid 
growth patterns with areas of hemorrhage and necrosis. Microscopic 
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examination reveals obvious stromal invasion with high grade nuclear 
features and irregularly branching highly cellular papillae with little or no  
stromal support. Psammoma bodies are commonly seen. As revealed in 
study by Naseer A Shaikh et al, the majority of patients present at 
advanced stage when the prognosis is poor.21 
B) MUCINOUS TUMORS: 
 
These tumors account for 10-15% of all ovarian tumors.22 They generally 
occur in older women. They may be associated with dermoid  cysts, 
Brenner tumors or mucinous tumors of other organs. 
1) Benign mucinous cystadenoma: 
 
These tend to be largest of all ovarian tumors. Most of these 
tumors are usually unilateral multilocular cystic masses containing  
viscous mucoid or watery material. Microscopically they show cysts or 
glands lined by mucinous columnar epithelium with minimal cellular 
stratification and basally located bland nuclei. 
2) Borderline mucinous cystadenoma: 
 
The lining epithelium shows stratification not more than 3 layers and 
may form filiform intracystic papillae with absent frank stromal invasion. 
Depending on the lining epithelium of cysts, these are classified as: 
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Intestinal type (85%) and Endocervical /mullerian type (15%) As in study 
by Shappell et al, borderline tumors are qualified as intraepithelial 
carcinoma based on the presence of marked cytologic atypia or a 
complex cribriform growth pattern involving the epithelium covering the 
surface of papillae or lining cystic spaces. Tumors with stromal invasion 
≤5 mm are classified as microinvasive carcinoma.23  
3) Malignant mucinous ovarian tumor (mucinous adenocarcinoma): 
 
These are relatively uncommon tumors accounting for 10% of 
ovarian cancers. They are multicystic with cut section showing both solid 
and papillary cystic areas with areas of hemorrhage and necrosis. As seen 
in study by Stephen S Raab et al, microscopically the lining epithelium 
shows stratification of more than 4 layers and atypical changes. Areas of 
necrosis and stromal invasion also seen. 24 
 
C) ENDOMETROID TUMORS: 
 
These tumors account for approximately 2-4% of all ovarian 
tumors and 10-20% of all ovarian cancers25. These occur in women in 
perimenopausal age. As seen in study by Karen A.Bell et al most 
endometroid tumors are carcinomas.26 
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Endometrioid carcinoma: 
 
These tumors present as solid, friable or cystic mass with hemorrhagic 
content. Histopathological examination shows that these resemble the 
ordinary type of endometrial adenocarcinoma hence the name. Study 
done by Falkenberry SS et al shows that 15-20% of endometroid 
carcinoma show synchronus endometrial adenocarcinoma.27-31 
D) CLEAR CELL TUMORS: 
 
Clear cell carcinomas constitute 6% of surface epithelial stromal 
Cancers.25,32   They most commonly occur in the 5th to 6th decade of life 
as seen in study by  by Crozeir MA et al 33,34. These are predominantly 
solid with cystic areas containing one or more white or yellow polypoid 
masses protruding in the lumen. As seen in study by Longacre TA et al, 
clear cell carcinoma shows a variety of patterns and cell types which are 
admixed. The common patterns are tubulocystic, papillary, reticular and 
solid sheets.35 Cores of papillae are lined by one or two layers of hobnail 
cells with clear cells forming solid sheets. The stroma in ovarian clear 
cell carcinoma often shows alternate mucoid and hyalinized change.36 
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 E) BRENNER TUMOR:  
 
These tumors constitute 1 to 2 % of all ovarian neoplasms25. 
Average age at presentation was between 30-50 years in study done by 
Ehrlich CE et al 37,38 . These are hormonally active accompanied by signs 
of hyperesternism. Most authors currently favor an origin from surface 
ovarian epithelium or cyst derived from them through the process of 
metaplasia. As seen in study Cuatrecasas et al(2009),Brenner tumor is 
seen in association with mucinous cystadenoma and transitional cell 
tumor of the bladder.39  Most Brenner tumors are benign. These are solid, 
sharply circumscribed and lobulated fibrous masses.37,38 These tumors 
consist of nests and trabeculae of transitional cells surrounded by 
abundant stroma. Nuclei of tumor cells are oval with longitudinal groove 
(coffee bean).  
 
F) TRANSITIONAL CELL CARCINOMA: 
 
These tumors in ovary are broadly similar to transitional cell 
carcinoma of urinary tract in architectural arrangement and they lack a 
benign or borderline Brenner component. As seen in study by Eichhorn, 
John et al mean age at presentation is around 50 to 58 years.39  Grossly 
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these are usually cystic with few solid areas. Microscopically solid or 
papillary growth pattern is seen and the papillae are multilayered.  
II. SEX CORD STROMAL TUMORS: 
 
These comprise of a heterogeneous group of neoplasms accounting for  
 
8% of all ovarian neoplasms25. They are the most common functioning  
 
ovarian tumors.  
 
A.1) GRANULOSA STROMAL CELL TUMOR: 
 
These comprise of two groups: 
 
1) The granulosa cell tumor 
 
2) The thecoma - fibroma group 
 
GRANULOSA CELL TUMOR: 
 
These are the ovarian neoplasms showing differentiation towards 
follicular granulosa cells. They are mainly of two types – Juvenile and 
adult granulosa cell tumor. Adult granulosa cell tumors account for 1-2 % 
of all ovarian tumors and 95% of all granulosa cell tumors. These occur 
in menopausal and postmenopausal age group. Three fourths are 
associated with hyperestrenism which leads to endometrial hyperplasia 
and carcinoma in approximately 5% of cases. These are unilateral with 
cystic and solid areas. Cut section shows solid areas, yellow to white in 
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color. The most common histologic patterns include diffuse, trabecular, 
insular, and microfollicular. An additional morphologic variant, a 
pseudopapillary pattern, may also be seen in granulosa cell tumors of 
both adult and juvenile type, and can give rise to problems in their 
distinction from transitional cell neoplasms was studied by Irving, Julie  
et al. 40 These tumors are potentially malignant. Juvenile granulose cell 
tumor usually presents in the first decade of life, almost all presenting 
within third decade. Young, Robert H. M.B et al found 82% of the 
prepubertal patients presenting with isosexual pseudo- precocity. 41 
Juvenile granulosa cell tumor differs from adult granulose cell tumor 
such that former shows nuclear hyperchromasia, increased mitotis, rare 
nuclear grooves and call exner bodies. 
A.2) THECOMA- FIBROMA GROUP: 
 
a) Thecoma: 
 
These constitute 4% of all ovarian tumors and are subclassified in 
typical and leutinized subtypes. They affect postmenopausal females. 
They show estrogenic manifestations. These are unilateral, yellow, solid 
and have a well-defined capsule, and are firm in consistency. They are 
composed of fascicles of plump spindle shaped cells. The nuclei are 
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round to spindle and have finely dispersed chromatin with pale, 
vacuolated lipid rich cytoplasm.42 Silver stains demonstrate reticulin 
fibrils investing around each tumor cells. 
 
 b) FIBROMA: 
 
  The most common tumor in the sex cord-stromal category, which 
accounts for 4% of human ovarian tumors, is the fibroma. Fibroma 
occurs invariably after puberty, which is often seen between 50-60 years.  
They may be associated with meigs syndrome or basal cell nevus 
syndrome. These are smooth, lobulated and firm in consistency with 
average 6 cm diameter. On cut section, these are white in color. These 
shows spindle shaped fibroblastic cells that grow in interlacing fascicles 
and whorls. The tumor cells have small ovoid nuclei with pointed ends. 
No cytologic atypia or mitotic activity is present. 43 
 
c) FIBROSARCOMA: 
 
These are the most common ovarian sarcomas. They affect older 
women. Grossly these are large, unilateral, solid tumors with 
hemorrhagic and necrotic areas. These are densely cellular, with spindle 
cell arranged in herringbone or storiform pattern. They exhibit moderate 
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to severe cytological atypia and high mitotic rate (average 4 - 25 
mitosis/10HPF).44 
e) Sclerosing stromal tumor of ovary: 
 
It is a rare ovarian neoplasm occurring predominantly in young 
women  and is histologically characterized by cellular heterogeneity, 
prominent vasculature, and a pseudolobular appearance composed of 
cellular and hypocellular areas. As seen in study by Kawauchi S et al, 
immunohistochemistry demonstrates an expression of vascular 
permeability factor/vascular endothelial growth factor(VPF/VEGF) in the  
luteinized theca like cells.45 Grossly they are solid tumors with white and  
yellow areas, edema and cyst formation.  
B) SERTOLI - LEYDIG CELL TUMOR: 
 
These tumors account for less than 0.5% of all ovarian tumors. 
They may occur at any age but common around 25 years. These often 
produce androgens. They vary in gross appearance from solid yellow 
lobulated masses to uni or multilocular cysts. Sertoli-Leydig cell tumors 
are subdivided into well-differentiated forms, tumors of intermediate 
differentiation, poorly differentiated tumors, and a fourth, heterologous 
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type. As in study by Oliva, Esther et al  EMA, inhibin, and 
chromogranin represent the most helpful triad of immunomarkers serving  
to exclude two common mimics of Sertoli cell tumors (endometrioid 
carcinoma [inhibin−; EMA+; chromogranin−] and carcinoid tumor 
[inhibin−; EMA+; chromogranin+]).46 
 
C) SEX CORD TUMOR WITH ANNULAR TUBULES: 
 
It is a distinctive ovarian tumor, which present with 
hyperestrenism. Its morphologic hallmark is the presence of simple and 
complex annular tubules containing eosinophilic hyaline bodies, which 
are often calcified. Tumors associated with Peutz –Jegher syndrome are 
typically multifocal, bilateral, calcified and usually benign in nature.47 
 D) GYNANDROBLASTOMA:  
 
It is an extremely rare tumor. It is the term used for sex cord – 
stromal tumor composed of a mixture in similar amounts of clearly 
identifiable granulosa-theca cells and sertoli leydig cell elements. The 
inor component should account at least 10% of the tumor.2 
III. LIPID CELL (LIPOID, STEROID CELL) TUMOR: 
 
This group consists of ovarian tumors composed of cells resembling  
 
steroid hormone secreting cells. The neoplastic cells may be lipid-free or  
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lipid-rich.  
 
They are subdivided into four subtypes: 
 
1. stromal luteoma 
 
2. leydig cell tumor – hilus / nonhilus  
 
3. adrenal cortical type 
 
4. not other wise specified 
 
 
LEYDIG CELL TUMOR: 
 
These are usually unilateral and grossly present as small dark 
reddish brown to yellow nodules. Microscopically these are composed 
large round to polygonal cells with abundant eosinophilic cytoplasm that  
shows positivity for fat stains.48 Endocrine atypia is common. About 25%  
of tumors have tendency to develop malignancy. Malignant tumors tend  
to be larger with foci of necrosis and hemorrhage.  
 
 IV. GERM CELL TUMORS: 
 
These tumors constitute approximately 30% of all ovarian 
neoplasms. Most of them are seen in children and young adults. 
Approximately 95% of tumors are benign cystic teratomas. The germ cell 
tumors recapitulate normal embryogenesis. The current pathogenetic 
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theory suggests origin from a meiotic germ cell. It could be due to failure 
of meiosis 1 or meiosis 2.  
A) DYSGERMINOMA: 
 
These are the most common malignant germ cell tumors of the 
ovary which account for 1 % of all ovarian cancers. As seen in study 
done by Archana Amatya et al,  it is the most common malignant tumor  
occurring children and young women and in patients with gonadal 
dysgenesis.49 Grossly they have convoluted external surface and solid 
gray white cut surface. Presence of calcification suggests underlying 
gonadoblastoma. Microscopically they show monotonous population of 
cells arranged in nests separated by fibrous septa with lymphocytic 
infiltration. The cells have abundant clear cytoplasm, prominent 
cytoplasmic membranes, round vesicular nucleus and central prominent 
nucleoli. The PAS stain helps in demonstrating the presence of 
intracytoplasmic glycogen. Liang Cheng et al revealed importance of 
OCT 4 marker in dysgerminoma.50 
 
B) YOLK SAC TUMOR (ENDODERMAL SINUS TUMOR): 
 
These neoplasm constitute 20 % of malignant germ cell tumors. 
External  surface is smooth and glistening. Cut section shows solid and 
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cystic areas. Areas of hemorrhage and necrosis also seen. These tumors 
have a more than one growth pattern recapitulating yolk sac 
development, which can be reticular/microcystic, solid, papillary, 
polyvesicular vitelline or hepatoid. Schiller Duval bodies are the 
characteristic feature of this tumor. Eosinophilic PAS +ve diastase 
resistant hyaline globules are a frequent finding in yolk sac tumors.51 
 
C) EMBRYONAL CARCINOMA: 
 
These tumors occur in young age group with a median age of 15 
years. They present with precocious puberty, vaginal bleeding, hirsutism 
and amenorrhea. They are large, unilateral exhibiting solid and variegated 
cut surface. Foci of hemorrhage and necrosis are present. Microscopy 
shows large primitive cells distributed in solid sheets. Occasionally 
papillae and abortive glandular structures are formed. Nuclei are round 
and vesicular. Numerous mitotic figures are present.52  
 
D) POLYEMBRYOMAS: 
 
These are very rare neoplasms containing large number of 
embryoid bodies at various stages of development embedded in primitive 
mesenchymal stroma. 
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E) CHORIOCARCINOMA: 
 
Primary ovarian choriocarcinoma are rare, highly malignant 
tumors  usually developing before puberty. Primary ovarian 
choriocarcinoma are usually a component of mixed germ cell tumor. 
Grossly they are hemorrhagic and friable. They show the typical 
bilamellar pattern with admixture of syncitial and cytotrophoblastic 
elements in a necrotic and hemorrhagic background.  
 
F) TERATOMA: 
 
These tumors are characterized by presence of tissues derived from 
two or all three embryonic layers.These are divided into three types. 
1) Immature teratoma 
 
2) Mature teratoma 
 
3) Monodermal teratoma 
 
 
1) IMMMATURE TERATOMA: 
 
 It is a malignant teratoma constituting 3% of all ovarian teratomas 
and 20% of all malignant germ cell neoplasms. It occurs in children and  
young adult with an average presentation of 20 years. Cut section shows  
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partly solid and cystic areas. Microscopy shows the tissues derived from 
all the three germ layers are present growing as disorganized mixture of 
mature and immature elements Prognosis of these tumors depends mainly  
on relative amount of  primitive neuroepithelial tissue. The most widely 
used grading system (Norris system) stratifies immature teratoma into 
three grades: 
 
Grade 1 - Rare, primitive neuroepithelium not greater than 1 hpf/ slide  
Grade 2 - Primitive neuroepithelium not greater than 3 hpf/ slide  
Grade 3 - Primitive neuroepithelium greater than or equal to 4 hpf/ slide  
 
2) MATURE CYSTIC TERATOMA: 
 
These are most common ovarian neoplasm accounting for 27–44% 
of all ovarian neoplasms. Two thirds of the patients are between 20 and 
40 years. These are almost always cystic. Cyst content is greasy, largely  
composed of keratin, sebum and hairs. Teeth are often present.  
Microscopically variable admixture of mature ectodermal, 
mesodermal and endodermal elements is seen. In almost 2% of the cases 
and particularly in older women, dermoid cysts undergo a secondary  
malignant change, usually in the form of squamous cell carcinoma, but  
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occasionally an adenocarcinoma, sarcoma, or other type of malignant 
neoplasm can occur. As observed by Ronnett,Brigitte M et al mature 
cystic teratoma can coexist with mucinous cystadenoma giving rise to 
pseudomyxoma peritonei or with Brenner tumor and fibrothecoma.53 
 
3) MONODERMAL TERATOMA: 
 
These are the teratoma in which one element predominates over all  
others. Struma ovarii is the most common which consists of thyroid 
follicles with eosinophilic colloid and lined by columnar or cuboidal cells  
with uniform round nucleus. Carcinoid tumors are the second common 
monodermal teratomas. Microscopic study shows round to cuboidal 
tumor cells with a round nucleus with coarse salt and pepper chromatin 
and small nucleoli. Four types are - mucinous, insular, trabacular and 
strumal carcinoids. 
 
G) MALIGNANT MIXED GERM CELL TUMOR: 
 
These comprise 5 to 10 % of all malignant germ cell tumors.54 
These show combination of two or more neoplastic germ cell elements. 
The combination of dysgerminoma and yolk sac tumor is the most 
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common. Proper identification of various components is necessary which 
requires careful gross examination and extensive sampling.  
 
V. MIXED GERM CELL - SEXCORD STROMAL TUMORS: 
 
GONADOBLASTOMA: 
 
These are tumors composed of a combination of germ cells and sex 
cord stromal cells. It is a rare tumor which occurs almost exclusively in 
dysgenetic gonads. They vary in gross appearance from soft and fleshy to  
firm and completely calcified. They show admixture of primitive germ 
cells resembling those of dysgerminoma with sex cord stromal cells 
resembling that of immature sertoli and granulosa cells arranged in small  
islands. Hyalinization and calcification are common. 
 
VI. TUMORS OF THE RETE OVARII: 
These are relatively uncommon tumors, which includes adenoma,  
cystadenoma and carcinoma.  
VII. MESOTHELIAL TUMORS: 
 
A) ADENOMATOID TUMOR:   
 
These are benign mesothelial tumors. Histologically they resemble 
their more common counterparts occurring in fallopian tube. 
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B) MESOTHELIOMA: 
 
     These are very rare. 
 
 
VIII. TUMORS OF UNCERTAIN ORIGIN: 
 
A) SMALL CELL CARCINOMA: 
 
There are two types of small cell carcinoma designated as hypercalcemic  
 
and pulmonary type. 
 
Hypercalcemic type: 
 
Extrapulmonary small cell carcinoma is a clinicopathological 
entity distinct from pulmonary small cell carcinoma. As revealed by 
Reckova M et al, it is a high-grade ovarian malignant tumor, which 
occurs in young females.55 It is usually unilateral with two thirds of 
patients showing hypercalcemia. The tumor is large and solid grey white 
resembling dysgerminoma or lymphoma. Large tumors may show 
hemorrhagic and necrotic areas. Two histological patterns are identified. 
A diffuse population of small, closely packed cells with scant cytoplasm 
and small nuclei constitute the common pattern. The nuclei are 
hyperchromatic, with fine chromatin and prominent nucleoli. Mitotic 
figures are numerous. Cytoplasmic hyaline globules are seen. In second 
type larger cells exhibiting epithelioid or rhabdoid features with abundant  
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eosinophilic cytoplasm and prominent nucleoli are seen.  
 
Pulmonary type: 
 
These highly malignant tumors resemble lung small cell 
carcinoma. Metastasis from lung primary should always excluded. 
 
B) FEMALE ADENEXAL TUMOR OF WOLFFIAN ORIGIN:  
 
These are benign unilateral tumors. These arise from mesonephric/  
wollfian remnants.56 The tumor  cells show diffuse, trabecular and 
microcystic growth pattern. Small to medium sized epithelial cells are 
embedded in fibrous stroma as seen in study by Karminjed MH et al.57 
Almost always inhibin positivity is also recorded. 
 
IX. SOFT TISSUE TUMORS NOT SPECIFIC TO OVARY: 
 
These include various mesenchymal neoplasms arising from those 
tissue elements for example smooth musle, nerves or blood vessels which 
are not involved in specific gonadal function. These may be leiomyomas 
as seen in study by Murakami M et al or leiomyosarcomas, 
rhabdomyomas, rhabdomyosarcomas, chondromas, chondrasarcomas or 
vascular tumors.58 
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X.METASTATIC TUMORS (SECONDARY TUMORS): 
 
The ovary is a common site of metastasis in female genital tract as 
observed by Mazur MT  et al.59 Colon , stomach, breast, uterus and lung 
constitute the common primary sites. As seen in study by Zhao et al most 
of the meatastatic tumors occurred in premenopausal patients and had 
bilateral presentation.60 Metastatic tumors in the ovary vary in 
appearance. In some cases the ovary is completely replaced by solid 
white tumor or cystic tumor with solid areas. The microscopic 
appearance varies with the nature of primary  
tumor. They resemble the primary to a variable degree. 
Immunohistochemical stains like CK7 and CK20 are helpful in 
establishing the diagnosis. 
Krukenberg tumor: 
 
These are adenocarcinomas with distinctive histological 
appearance. They show typical mucin filled signet ring cells associated 
with striking proliferation of ovarian stroma.  Stomach is the usual 
primary site. Grossly, these are solid bosselated masses with grey white 
cut surface. Special stains for mucin and immunostains for epithelial 
marker are helpful in diagnosis.61  
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               MATERIAL AND METHODS 
 
 
 
STUDY DESGIN:  Descriptive study. 
 
 
PLACE OF THE STUDY AND STUDY PERIOD: 
 
This study was conducted in the Department of Pathology, 
Coimbatore Medical College, Coimbatore. The study period extended 
from March 2009 to June 2010.  
 
SAMPLE SIZE:                
 
This study included all the specimens of ovarian tumors sent for  
histopathological examination to the Department of Pathology at 
Coimbatore  Medical College, Coimbatore between March 2007 & 
February 2010.  
 
INCLUSION CRITERIA: 
 
1. All the ovarian tumors, irrespective of their clinical features, stage of  
 
    the disease or type of surgical procedure implemented were included. 
 
2. Hysterectomy specimens with incidental ovarian tumors were also     
    included. 
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EXCLUSION CRITERIA: 
 
Non neoplastic ovarian lesions like simple ovarian  cyst, tubo-
ovarian mass and polycystic ovaries were excluded. 
 
METHODOLOGY: 
 
Relevant data like parity, clinical presentation, age of the patient 
was collected in a proforma. For specimens of ovarian tumors from May 
2009 to February 2010, gross observation of the specimens received was  
done. For proper fixation, tumors were cut serially at 1cm thickness. The 
specimens were  fixed in 10% formalin for 24-48 hours. After fixation, 
sections were given from representative areas. Sections were cut at 4-5 
micrometer thickness &  stained with H&E. Slides and blocks were 
retrieved for cases from March 2007 to April 2009.  All stained 
histopathology slides were studied in detail. Histopathology reports for 
each tumor were retrieved from department of pathology, Coimbatore 
Medical College. Special stains of PAS, Reticulin were done whenever 
necessary. All details of the specimen consisting of gross features, 
microscopic features and final diagnosis were studied. World Health 
Organization classification was used for classifying the tumors. Analysis  
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of the data was done to find out the incidence of various types of tumors,  
age of presentation of various tumor types, gross features and 
histopathological patterns of individual tumor types. Incidence of benign  
versus malignant tumors was studied. This was a descriptive study and 
analysis of data was done using chi square test and logistic regression 
analysis. 
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             OBSERVATIONS AND RESULTS 
 
 
The incidence and clinical presentation of the different ovarian 
tumors is extremely variable. The preoperative diagnosis of the tumors is 
often difficult with only clinical examination and even on exploration, 
though some investigations like peritoneal fluid cytology or serum LDH 
may help in predicting the nature of pathology. Hence one has to depend 
on the microscopic appearance of the tumor for further management.8 
The present study of ovarian tumors was undertaken for a period of three 
years from March 2007 to February 2010. Totally 301 cases were studied 
in this period. 
TABLE 1: AGE DISTRIBUTION 
 
Sr. No.        Age (Years)    No. Of  Cases 
       (n =301) 
    Percentage (%) 
    1.           <20            13        04.32 % 
    2.          21-30            79        26.24 % 
    3.          31-40            77        25.59 % 
    4.          41-50            68        22.59 % 
    5.          51-60            46        15.28 % 
   6.           >60            18        05.98 % 
 
 
Table 1 shows that the majority of tumors ie. 270 out of 301 (89.7 
%) were present between 3rd to 6th decade. Below 20 years and above 60  
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years only one tenth tumors were seen. Approximately 50 % tumors were  
present in reproductive age group. 
                               TABLE 2 :  PARITY STATUS 
 
 
                         
 
 
                                 
 
                                                         
                      
 
Table 2 shows the parity status observed in the present study. 
There were 29(9.63%) nulliparous patients and 145(48.17%) were of 
parity one or two. Patients with parity three or more were 127(42.19%). 
                               TABLE 3:  AGE AT MENARCHE 
 
 
Sr.No. Age At Menarche (Yr) No. Of Cases (n =301) Percentage (%)
1. <11 10 3.32 % 
2. 11-12 46 15.28 % 
3. 12-13 94 31.23 % 
4. 13-14 47 15.61 % 
5. 14-15 65 21.59 % 
6. >15 39 12.96 % 
 
Table 3 shows the age at menarche recorded for the patients in the  
Sr.No.     Parity    No. Of Cases 
       (n =301) 
 Percentage(%) 
    1.          0           29        9.63 % 
    2.          1           51          16.94 %    
3. 2           94         31.23 %   
    4.          3           97      32.22 % 
5. ≥4     30        9.97 % 
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present study. Majority of the patients, 245 (81.39%) attained menarche 
after the age of 12. The other 56 patients attained menarche before age of  
12.     
                            TABLE 4 : MENSTRUAL STATUS  
 
Sr.No. Category No. Of Cases (n =301) Percentage (%) 
1. Premenopausal 211 70.10 % 
2. Postmenopausal 90 29.90 % 
 
Table 4 shows menstrual status among the patients of the present 
study.  Premenopausal age group was more common than post 
menopausal, contributing to 70.10% of the tumors. 
                           
                           TABLE 5:  MODE OF PRESENTATION 
 
 
Sr.No.         Symptom   No. Of Cases   Percentage (%) 
    1.   Abdominal pain           161          53.49 % 
    2.   Mass per abdomen             81          26.91 % 
    3.   Ascites             25            8.30 % 
    4.   Menstrual irregularities             21            6.98 % 
    5.   Urinary complaints              6            1.99 % 
    6.   Asymptomatic              7            2.32 % 
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Table 5 shows that abdominal pain was the commonest 
presentation followed by mass per abdomen. Asymptomatic ovarian 
tumors were least common. 
                    
                      TABLE 6:  LATERALITY OF THE TUMORS 
 
 
Sr. No. Laterality No. Of Cases (n =301) Percentage (%) 
1. Unilateral 268 89.04  % 
2. Bilateral 33 10.96  % 
 
Table 6 shows the incidence of unilateral and bilateral tumors. 
Most of  the tumors were unilateral. 33 out of the 301 tumors (11%) had  
bilateral presentation.  
 
         TABLE 7: INCIDENCE OF BILATERALITY IN BENIGN  
              
                            VERSUS MALIGNANT TUMORS 
 
 
Sr.No. Type Unilateral Bilateral Percentage (%) 
1. Benign 213 12 5.63% 
2. Malignant 55 21 38.18% 
 
 
Table 7 shows that 12 out of 213 (5.63%) benign tumors and 21 
out of 55 (38.18%) malignant tumors presented bilaterally. Among 
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bilateral tumors 21 (64%) were malignant as against 12(5.63%) benign 
tumors. Thus malignant tumors were common to present bilaterally.                           
                                                 
TABLE 8: INCIDENCE OF BILATERALITY IN THE MAJOR 
 
                             HISTOPATHOLOGICAL SUBTYPES     
 
 
 
  
Table 8 shows that all the metastatic tumors had bilateral presentation  
 
whereas none of the sex cord stromal tumors were bilateral. Out of 12  
 
cases of endometrioid carcinoma in present study 6 (50%) had bilateral  
 
presentation.  
 
 
 
 
                 
Sr.No. Microscopic   Type 
No.of 
Cases 
(n=301) 
Bilaterality Percentage (%) 
1. Surface Epithelial Tumors 243 24 9.88 % 
2. Germ Cell Tumors  22 5 22.73 % 
3. Sex Cord Stromal Tumors 32 0 0 % 
4. Metastatic Tumors 4 4 100 % 
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    TABLE 9:   MAJOR HISTOPATHOLOGICAL SUBTYPES 
 
 
 
 
Table 9 shows the incidence of the major histopathological subtypes of  
 
ovarian tumors. The most common histopathological pattern encountered  
 
in the present  study was surface epithelial tumors followed by germ cell  
 
tumors. Metastatic tumors were the least common variety.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    
Sr.No. Microscopic Type No. Of Cases (n =301) Percentage (%)
1. Surface Epithelial Tumors 243 80.73 % 
2. Germ Cell Tumors 22 10.63 % 
3. Sex Cord Stromal Tumors 32 7.31 % 
4. Metastatic Tumors 4 1.33 % 
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                  TABLE 10:  LATERALITY IN INDIVIDUAL  
 
                         HISTOPATHOLOGICAL SUBTYPE 
 
 
Sr.No Diagnosis Bilateral Unilateral Total (n =301) 
1. Serous Cystadenoma 4 103 107 
2. Serous Cystadenofibroma 1 3 4 
3. Mucinous Cystadenoma 2 62 64 
4. Mucinous Cystadenofibroma - 2 2 
5. Endometrioid Adenofibroma - 2 2 
6. Mature Cystic Teratoma 5 21 26 
7. Fibroma - 8 8 
8. Thecoma - 1 1 
9. Fibrothecoma - 2 2 
10. Granulosa  Cell Tumor - 6 6 
11. Sertoli Cell Tumor - 2 2 
12. Sex Cord  Tumor With Annular Tubules - 1 1 
13. Borderline Serous Tumor - 2 2 
14. Serous Cystadenocarcinoma 6 14 20 
15. Borderline Mucinous Tumor 1 10 11 
16. Mucinous Cystadenocarcinoma 4 12 16 
17. Endometrioid   Carcinoma 6 6 12 
18. Clear Cell Carcinoma - 3 3 
19. Dysgerminoma - 4 4 
20. Mixed Germ Cell Tumor - 2 2 
21. Granulosa Cell Tumor - 2 2 
22. Metastatic 4 - 4 
 
 
Table 10 shows the laterality observed in individual 
histopathological subtypes. Among benign tumors, mature cystic 
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teratoma was common to present bilaterally. In primary ovarian 
carcinomas, endometrioid carcinoma and serous cystadenocarcinoma 
showed higher incidence of bilaterality. 
 
                                TABLE 11: SIZE OF THE TUMORS  
 
 
Sr.No. Size Of Tumor (cm) No. Of Cases (n =301) Percentage (%) 
1. <10 137 45.51 % 
2. 11-20 139 46.18 % 
3. 21-30 24 7.97 % 
4. >30 1 0.33 % 
 
  
Table 11 shows the distribution of tumors according to their size.  
 
Majority of the tumors i.e. 276 (91.69%) were less than 20 cms in the  
 
largest dimension. Only 24 tumors had their largest dimension between  
 
21 to 30 cms. The largest tumor was measuring 32x25x12 cms which  
 
was unilateral benign serous cystadenoma affecting a 27 year old lady.  
 
Bilateral endometrioid adenocarcinoma was the smallest tumor in this  
 
study measuring 3x2x1.5 cms present in a 55 year lady. 
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TABLE 12:   GROSS FEATURES 
 
 
 
 
 
 
 
 
 
Table 12 shows the details of the gross morphological features of 
the ovarian tumors included in the present study. The commonest gross 
morphology was the cystic nature of the tumors contributing to 68.44%. 
The tumors presenting with gross cystic morphology were benign tumors 
especially of surface epithelial category. Among tumors with solid or 
complex morphology, majority were malignant. 
 
                                TABLE 13: NATURE OF THE TUMORS 
                                    
 
 
Table 13 shows that out of 301 cases studied, majority were benign  
 
tumors 225 (74.75%), followed by malignant 63(20.93 %) and 13    
  
(4.32 %) cases of borderline tumors. 
Sr.No. Gross Feature    No. Of Cases 
    (n =301) 
  Percentage (%) 
1.        Cystic           206        68.44 % 
2.         Solid             57        18.94 % 
3.  Cystic & Solid             38        12.62 % 
Sr. NO Nature Of Tumor No. Of Cases (n =301) Percentage (%) 
1. Benign 225 74.75 % 
2. Borderline 13 4.32 % 
3. Malignant 63 20.93 % 
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TABLE 14: HISTOMORPHOLOGICAL TYPES OF THE 
OVARIAN TUMORS 
 
Sr.No. Type  Of  Tumor No.Of Cases 
(n =301) 
Percentage (%) 
1. Serous Cystadenoma 107 35.54 % 
2. Serous Cystadenofibroma 4 1.33 % 
3. Borderline Serous Tumor 2 0.66 % 
4. Serous Cystadenocarcinoma 20 6.64 % 
5. Mucinous Cystadenoma 64 21.26 % 
6. Mucinous Cystadenofibroma 2 0.66 % 
7. Borderline Mucinous Tumor 11 3.65 % 
8. Mucinous Cystadenocarcinoma 16 5.32 % 
9. Endometrioid Adenofibroma 2 0.66 % 
10. Endometrioid   Carcinoma 12 3.99 % 
11. Clear Cell Carcinoma 3 0.99 % 
12. Mature Cystic Teratoma 26 8.64 % 
13. Dysgerminoma 4 1.33 % 
14. Mixed Germ Cell Tumors 2 0.66 % 
15. Fibroma 8 2.66 % 
16. Thecoma 1 0.33 % 
17. Fibrothecoma 2 0.66 % 
18. Granulosa  Cell Tumor 8 2.66% 
19. Sertoli Cell Tumor 2 0.66 % 
20. SCTAT 1 0.33 % 
21. Metastatic 4 1.33 % 
                                  (SCTAT- Sex Cord Tumor with Annular Tubules) 
 
Table 14 shows the incidence of each histomorphological subtype. 
Benign serous cystadenoma was the commonest histopathological pattern 
encountered in present study contributing to 35.54% followed by benign 
mucinous cystadenoma. Only single case each of thecoma and sex cord 
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tumor with annular tubules was seen. No transitional cell tumors were 
seen in this study.  
 
                          TABLE 15:  AGE DISTRIBUTION OF THE 
 
     BENIGN / BORDERLINE / MALIGNANT OVARIAN TUMORS 
 
                           
AGE(Yr) BENIGN BORDERLINE MALIGNANT TOTAL 
<20 9 - 4 13 
21-30 67 5 7 79 
31-40 67 1 9 77 
41-50 45 4 19 68 
51-60 28 3 15 46 
>60 9 - 9 18 
 
 
Table 15 shows age distribution of benign and malignant ovarian tumors. 
Malignant tumors commonly affected older age group (>40 years) with 
only malignant germ cell tumors involving younger age group. On the 
contrary, benign tumors predominantly involved patients < 40 year age. 
The increasing incidence of malignancy with increasing age was found to  
be statistically significant. 
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TABLE 16: AGE DISTRIBUTION OF 
 
                          THE MAJOR TUMOR CATEGORIES 
 
 
AGE 
(Yr) 
Surface 
Epithelial 
Tumors 
Germ Cell 
Tumors 
Sex cord 
Stromal 
Tumors  
Metastatic 
Tumors  
Total 
<20            6         4         3        -      13 
21-30          61       13         3        2      79 
31-40         60       11         6        -      77 
41-50         60         2         5        1      68 
51-60         41         2         3        -      46 
>60         15         -         2        1      18 
Total       243       32        22        4     301 
 
 
 
Table 16 shows the distribution of major histopathological types 
according to age. Surface epithelial tumors were uncommon to present in 
adolescent age group whereas germ cell tumors had predilection for this 
age group. After age of 40 years, surface epithelial was the 
predominating category with rare germ cell tumors. 
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TABLE 17: AGE DISTRIBUTION OF THE VARIOUS 
 
HISTOMORPHOLOGICAL TYPES OF THE TUMORS 
 
NO Type  Of  Tumor <20 Yr. 
21-
30 
31-
40 
41-
50 
51-
60 
>60 
Yr. 
1. Serous Cystadenoma 2 35 29 23 13 5 
2. Serous Cystadenofibroma 1 1 1 - 1 - 
3. Borderline Serous Tumor - 1 1 - - - 
4. Serous Cystadenocarcinoma - 1 2 9 6 2 
5. Mucinous Cystadenoma 3 17 20 15 8 1 
6. Mucinous Cystadenofibroma - - -  1 1 
7. Borderline Mucinous Tumor - 4 - 4 3 - 
8. Mucinous Cystadenocarcinoma - 2 5 3 4 2 
9. Endometrioid Adenofibroma - - - - 1 1 
10. Endometrioid   Carcinoma - - 2 6 2 2 
11. Clear Cell Carcinoma - - - - 2 1 
12. Mature Cystic Teratoma - 11 11 2 2 - 
13. Dysgerminoma 2 2 - - - - 
14. Mixed Germ Cell Tumors 2 - - - - - 
15. Fibroma 2 - 4 2 - - 
16. Thecoma - - - - 1 - 
17. Fibrothecoma - 1 - - - 1 
18. Granulosa  Cell Tumor - 1 1 3 2 1 
19. Sertoli Cell Tumor 1 1 - - - - 
20. SCTAT - - 1 - - - 
21. Metastatic - 2 - 1 - 1 
     
Table 17 shows the age distribution of each histopathological 
subtype of ovarian tumors included in present study. In patients less than 
20 years of age, most of the tumors were benign except malignant germ 
cell tumors which affected this age group most commonly. 
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TABLE 18: VARIABLES RELATED TO THE RISK OF 
MALIGNANCY 
Sr. 
No. VARIABLE TOTAL MALIGNANT % 
p 
VALUE 
1. AGE:     
 ≤50 Years 237 49 20.67% p <0.01 
*  >50 Years 64 27 42.19% 
      
2. GRAVIDITY:     
 ≤1 80 32 40.00% p < 0.01 
*  >1 221 44 19.91% 
      
3. MENOPAUSAL STATUS     
 PRE MENOPAUSAL 211 40 13.29% p < 0.01 
*  POST MENOPAUSAL 90 36 40.00% 
      
4. TUMOR MORPHOLOGY:     
 CYSTIC 206 12 3.97%  
p < 0.01 
* 
 SOLID 57 42 73.68% 
 COMPLEX 38 22 57.89% 
      
5. TUMOR DIAMETER:     
 ≤10 cm 137 29 21.17% p > 0.05  >10 cm 164 47 28.66% 
      
6. LATERALITY     
 UNILATERAL 268 55 20.52% p < 0.01 
*  BILATERAL 33 21 63.64% 
      
7. AGE AT MENARCHE     
 ≤12  YEARS 56 17 30.36% p > 0.05  >12   YEARS 245 59 24.08% 
* = Significant at 1% level (p < 0.01 ) 
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TABLE 19: LOGISTIC REGRESSION ANALYSIS 
 
Variable Log Odds(B) S.E. Wald Df Prob. Sig. Exp(B)
Age 1.166 0.622 4.072 1 0.01 * 1.181 
Parity -1.562 0.468 11.160 1 0.00 * 0.210 
Age at Menarche -0.077 0.486 0.025 1 0.87 Ns 0.926 
Menstrual status 1.497 0.603 6.170 1 0.01 * 4.469 
Laterality 1.439 0.525 7.509 1 0.01 * 4.217 
Size -0.051 0.384 0.018 1 0.89 Ns 0.950 
Tumor Morphology 3.145 0.385 66.669 1 0.00 * 23.213
 
* = Significant                     NS = Not significant 
 
 
Table 18 and 19 show the risk of malignancy associated with various 
variables related to ovarian tumors. Logistic regression analysis is 
applied to predict the probability of a particular outcome in relation to 
several other independent variables. Here, Logistic regression analysis 
was used to find out the probability (Odds) of the patients developing 
malignant tumor. The model was constructed based on the set of 
independent variables listed above. Increasing age, nulliparity or low 
parity, postmenopausal status, bilaterality and complex or solid tumor 
morphology conferred higher risk of malignancy. Early menarche and 
size of the tumor did not correlate with increased risk of malignancy.  
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            TABLE 20:  PREDICTIBILITY OF THE MODEL 
 
 
  Predicted by the equation 
 
Observed 
data 
 Malignant Benign Total      Percent     
    Correct 
Malignant 208 17 225      92.44% 
Benign 20 56 76      73.68% 
 
Using the above seven variables together, a model was created to predict 
the risk of malignancy in a tumor. The following statistics was used to 
assess the overall effectiveness of the model. 
 
-2 Log Likelihood      190.312 
 
 Cox & Snell - R2          0.392 
  
 Nagelkerke - R2             0.579 
 
Chi-Square Df Significance
149.851 7 * 
 
* - Significant at 1 % level (P<0.01) 
Overall 87.71% of the cases were correctly classified by the model. The –
2 Log Likelihood value is 190.312 which was used to test the 
effectiveness of the model using chi-square test. The chi-square value 
was 149.851, which was significant at 1% level indicating that the model 
fits the data well.  
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DISCUSSION 
 
Because of the anatomical location, ovarian tumors may remain 
unnoticed for a long period of time. These tumors can cause abdominal 
pain and abdominal distension. Based on histological patterns, these 
tumors are divided into benign, borderline and malignant. The common 
variants are epithelial cell tumors, germ cell tumors, and sex cord stromal 
Tumors. The ovary is one of the common sites to get metastatic deposits 
from other abdominal malignancies.62 
 
 
DISTRIBUTION OF OVARIAN TUMORS ACCORDING TO  
 
AGE: 
 
Ovarian tumors are common in all age groups and no age is 
exempted. The age range in the present study was 14 to 76 years. The 
youngest patient in this study was a 14 year old girl with left sided 
dysgerminoma measuring 17x14x10 cms which is the most common 
germ cell tumor of  adolescent age group. She presented with mass per 
abdomen. The oldest patient was a 76 year old lady with unilateral serous 
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cystadenocarcinoma with omental deposits. She presented with ascites 
and the tumor was measuring 5x4x3 cms. The maximum number of cases 
in present study were between 21 and 60 years. This age group included 
89.7% of tumors. This was in concordance with following studies: 
 
  
The comparative analysis with above studies revealed similar results as 
present study.  2nd  to 5th  decade was the most common age group 
affected. Adolescent age group constituted 4.32 % in this study. This is 
also comparable to study done by Deshpande et al where the incidence 
of ovarian tumors in this age group was 4.2 %.67 
 
 PARITY STATUS: 
 
Increasing parity is associated with a reduction in the risk of ovarian 
cancer, but it is not clear whether this association applies to all the 
histopathological types and to borderline tumours.68 Nulliparity and low 
Sr.No.  Age 
(Yr) 
Present  
study 
   Pilli  
   et al 63 
  R Jha  
    et al 64 
 Kayastha   
    et al 65 
  Kar  
 et al 66 
    1. <20 4.32 %       7 %     6.8 %     6.3 %       7  % 
    2. 21-30 26.24 %     58 %    20.5 %    28.5 %      42 % 
    3.  31-40  25.59 %    26.7 %    27.4 % 
    4.  41-50  22.59 %     30 %    21.1 %    26.3 %     46 % 
    5.  51-60  15.28 %    14.3 %    11.6 %   
   6.  >60   5.98 %       5 %    10.6 %      5 % 
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parity were associated with increased relative risk of ovarian tumors in 
the present study. In this study, tumors in nullipara and women with low 
parity (two children) contributed to 57.80 % of all tumors which was 
consistent with findings of study done by Kayastha et al.65 In their study 
tumors in nullipara and women with low parity contributed to 58.93 %. 
Similar results were obtained in study by Adami et al.68 
 
 
AGE OF MENARCHE: 
 
Increased risk of ovarian tumors associated with early menarche is put  
forward by various studies like study by Adami et al and Hildreth et 
al.68,69 In the present study only 18.60 % patients attained menarche 
before 12 years of age. This is in contrast to the above mentioned studies. 
As in present study, Kayastha et al recorded similar finding of 91.7 % 
tumors in patients with menarche after age of 12 years.65 This difference 
may be explained by the fact that both studies by Adami et al and 
Hildreth et al were conducted in western population where as the present 
study and study by Kayastha et al were conducted in Indian subcontinent. 
The onset of menarche is influenced by female biology, as well as 
genetic and environmental factors, especially nutritional factors. Females 
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from western countries have been shown to have younger age at 
menarche with possible role played by nutritional status.  
 
 
MENSTRUAL STATUS: 
 
Similar to other studies, present study revealed higher incidence of 
ovarian tumors in reproductive age group. Higher incidence of ovarian 
tumors was observed in 21-40 years and premenopausal age group. In 
postmenopausal patients, comparatively higher incidence of malignant 
tumors was observed. Similar findings were recorded in study by            
R  Jha et al and also in study by Pilli et al and by Merino et al.63,64,70 
 
 
MODE OF PRESENTATION : 
 
 
Some of the ovarian tumors may be incidentally diagnosed on ultrasound 
whereas others may be symptomatic. Present study reveals that the 
presentation of the ovarian tumors is variable. If patient presented with 
more than one complaint then the predominant symptom was considered 
as the presenting symptom. In the present study the commonest 
presenting symptom was pain in the abdomen 209 (69.43%) followed by 
mass abdomen 43 (14.28 %). Ascites was present in 23 (7.64 %) patients 
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whereas menstrual irregularities including post menopausal bleeding in 
19 (6.31 %). Asymptomatic patients were only 7 (2.32 %) with these 
tumors being incidentally diagnosed on ultrasound done for other cause 
or as a routine work up. The results comply well with a study carried out 
by Rashid et al, in which abdominal pain was the commonest presenting 
complaint (59%) followed by abdominal mass/distension (37%).71 Study 
done by Sumaria Yasmin et al showed similar findings.7 In contrast to 
this, in another retrospective analysis by Jamal et al the commonest 
mode of presentation was bleeding per vaginum, followed by pain 
abdomen, pelvic mass and gastric intestinal symptoms.72 
 
UNILATERAL / BILATERAL PRESENTATION: 
 
In the present study most of the tumors were unilateral. Only 33 out 301 
tumors (constituting almost 11%) had bilateral presentation. Among 
bilateral tumors 21 (64%) were malignant. Thus among bilateral tumors, 
malignant tumors are more common . 21 out of 76 (27.63 %) malignant 
tumors presented bilaterally as against 12 out of 225 (5.33 %) benign 
tumors. This finding was similar to study done by R Jha et al who 
encountered only 6.7 % benign tumors and 42.3 % malignant tumors 
presenting bilaterally.64  Compared to the present study, higher incidence 
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of bilaterality was present in the study by Kar et al which showed 26.8%  
bilaterality.66 Out of 12 cases of endometrioid carcinoma present in this 
study 6 (50%) had bilateral presentation. Serous carcinoma showed 42.85 
% and mucinous carcinoma 33.33 % bilaterality. The most common 
benign tumor to present bilaterally was mature cystic teratoma, which 
showed 23.8 % bilaterality. Tumours in the sex cord stromal category are 
almost always confined to a single ovary, similar observation is made in 
this study.7  From 32 sex-cord stromal tumors, none had bilateral 
presentation. As seen in study by Zhao et al most of the meatastatic 
tumors occur in premenopausal patients and have bilateral presentation.60 
In the present study all the metastatic tumors had bilateral presentation. 
Ovarian dermoids can be bilateral in  15% cases.73 
 
 
SIZE OF THE TUMOR: 
 
Largest dimension of the tumor was utilized to categorize the tumors 
according to the size. In present study tumors ranged in size from 3cms to 
32 cms. Almost all the tumors i.e. 276 (91.69%) were less than 20 cms in 
the largest dimension. Only 24 tumors had their largest dimension 
between 21 to 30 cms. The largest tumor was measuring 32x25x12 cms 
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which was unilateral benign serous cystadenoma affecting a 27 year old 
lady. Bilateral endometrioid adenocarcinoma was the smallest tumor in 
this study measuring 3x2x1.5 cms present in a 55 year lady.This finding 
correlated with study by Pilli et al, In their study the largest tumor 
measured 33x23x22 cms and smallest one measured 3x2x1 cms.63 
 
 
GROSS FEATURES : 
 
 
In the present study, 215 out of 301 (71.43 %) tumors had purely cystic 
architecture. Solid tumors were 57 out of 301 and thus comprised  18.94 
%. Combined solid and cystic presentation was present in 29 tumors 
(9.63 %). Study done by Kar et al  had  58.21 % cystic tumors, 13.43 % 
solid and 28.36 % combined solid and cystic tumors.66 The relatively 
high proportion of tumors with complex architecture and less percentage 
of cystic tumors in study by Kar et al can be explained by the fact that 
this study had more number of malignant tumors. Patients with solid or 
complex ovarian tumors are at high risk of ovarian malignancy was 
shown in study done by McDonald JM et al.74   
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HISTOPATHOLOGICAL PATTERNS: 
 
In this study WHO classification was implemented to classify the tumors. 
Surface epithelial tumors constituted the most common category in the 
present study contributing to 80.73 % of all tumors followed by germ cell 
tumors, sex cord stromal tumors and metastatic tumors in decreasing 
order of frequency as seen in other studies from India and neighboring  
countries like Pakistan and Nepal. 
 
 
Benign serous cystadenoma was the commonest tumor type with 35.54%  
of tumors. This was followed by benign mucinous  cystadenoma having 
incidence of  21.26%. Cases of Serous, mucinous and endometrioid 
cystadenofibromas were also reported. Among malignant tumors, serous 
Histopatho- 
logical type 
Present  
study 
Shahbaz 
et al 75 
Naseer   
 et al 21 
Kar  
et al 66 
Pilli 
 et al  63 
Kayasth 
   et al 65 
Surface 
Epithelial 
Tumors 
80.73 % 83.3%  81.0% 79% 70.9% 72.6% 
Germ Cell 
Tumors 
10.63 %  14.0% 10.95% 16% 21.2% 25.3% 
Sex Cord 
Stromal  
Tumors 
7.31 % 2.7% 5.03% 1.5%  6.7% 2.10% 
Metastatic 
Tumors 
1.33 % - 1.58% 3.5%  0.7%     - 
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cystadenocarcinoma was the most common category followed by 
mucinous cystadenocarcinomas. Cases of endometrioid and clear cell  
carcinomas were also present. In borderline surface epithelial tumor 
category borderline mucinous tumor dominated the category along with 
only 2 cases of serous borderline tumors. No transitional cell tumors were 
seen in this study. Benign mature cystic teratoma was the most common 
germ cell tumor whereas fibroma and granulosa cell tumor were the most 
common sex cord stromal tumors. Metastatic Krukenberg tumors were 
also present. Single case of sex cord tumor with annular tubules was 
seen. Some differences in incidence of certain ovarian tumors in the 
study population were noticed when compared to other studies. The most 
marked one was the higher incidence of endometrioid adenocarcinoma in 
the present study, with 12 cases being reported. Another important 
feature regarding this tumor category was high incidence of bilateral 
presentation which was observed in 50% cases. Another important 
difference was in the incidence of the borderline surface epithelial tumors 
with higher incidence recorded in present study. Both differences in 
tumor morphology, the higher incidence of endometrioid carcinoma type 
and borderline grade are among better prognostic criteria. 
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Sr  
No. 
              Type  Of  Tumor   Present  
   Study 
Naseer   
 et al 21 
 R Jha 
 et al  64 
1.  Serous Cystadenoma    35.54 % 42.07 27.33%
2.  Serous Cystadenofibroma      1.33 % 0.62% 
3.  Borderline Serous Tumor      0.66 % - - 
4. Serous Cystadenocarcinoma      6.64 % 8.78% 7.45% 
5.  Mucinous Cystadenoma     21.26 % 16.85% 13.04%
6.  Mucinous Cystadenofibroma             0.66 % - 
7.  Borderline Mucinous Tumor      3.65 % - - 
8.  Mucinous Cystadenocarcinoma         5.32 % 12.11% 3.73% 
9.  Endometrioid Adenofibroma     0.66 % - - 
10.  Endometrioid   Carcinoma      3.99 % - - 
11.  Clear Cell Carcinoma      0.99 % - - 
12.  Mature Cystic Teratoma       8.64 % 7.2% 40.37%
13.  Dysgerminoma       1.33 % 2.73% - 
14.  Mixed Germ Cell Tumors       0.66 % - - 
15.  Fibroma       2.66 % 1.29% 0.62 
16.  Thecoma      0.33 % 0.41% 1.86 
17.  Fibrothecoma      0.66 % - - 
18.  Granulosa  Cell Tumor      2.66%  3.6% 0.62 
19.  Sertoli Cell Tumor      0.66 % - - 
20. SCTAT      0.33 % - - 
21.  Metastatic      1.33 % 1.58% 1.24 
                       (SCTAT- Sex Cord Stromal Tumor with Annular Tubules) 
 
BENIGN / BORDERLINE / MALIGNANT: 
 
 
Out of 301 cases studied, majority were benign tumors [225 
(74.75%)], followed by malignancy [63(20.93 %)] and [13(4.32 %)] 
cases of borderline malignancy were found. 
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These findings were similar to studies done by Pilli et al and Nasser et al 
other studies recorded higher incidence of benign tumors. 
 
AGE WISE DISTRIBUTION OF   BENIGN / BORDERLINE /  
 
MALIGNANT TUMORS: 
 
 Under age of 20 years, benign tumors were common than 
malignant tumors. All the malignant tumors in this age group belonged to 
germ cell tumors, dysgerminoma or malignant mixed germ cell tumor. 
Under age of 40 years majority of the tumors were benign with malignant 
tumors contributing to only 14.10%. Above the age of 40 years much 
higher incidence of malignancy was noted with 37.88% malignant 
tumors. 
 
 Sr. 
No. 
Nature Of  
Tumor 
Present  
study 
Pilli  
et al 63 
Naseer 
et al 21 
R Jha  
et al 64 
Kayastha 
et al 65 
Sumaria 
et al 7 
 1. Benign 74.75 % 75% 68.25% 83.9% 90.5% 89.71% 
 2. Borderline   4.32 % 3% 0.72% - - - 
 3. Malignant 20.93 % 22% 30.96% 16.1% 9.5% 10.29% 
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VARIABLES RELATED TO RISK OF MALIGNANCY: 
 
Chi square test and logistic regression analysis were applied to 
evaluate the risk of malignancy associated with various parameters 
analyzed in the present study. To find out the risk factors to predict 
malignancy in tumors, seven independent variables were selected. These 
were age, parity, age at menarche, menstrual status, laterality, size and 
tumor morphology. Out of these risk factors studied, increasing age 
nulliparity or low parity, postmenopausal status, bilaterality and complex 
or solid tumor morphology conferred higher risk of malignancy. Early 
menarche and size of the tumor did not correlate with the increased risk 
of malignancy. Among all the risk factors evaluated, bilaterality 
conferred 4 times increased risk of malignancy over unilateral tumors. 
Tumor morphology was the most important risk factor, predicting 23 
times increased risk of malignancy in complex and solid tumors 
compared to cystic tumors. Using these seven risk factors together as a 
model to predict the risk of malignancy in a given tumor, 92.44 % of the 
cases could be correctly predicted as being malignant and 73.68 % of the 
cases as benign. Overall, the model predicted 87.71% of the cases 
correctly into their respective groups. (i.e. Malignant or Benign)                                    
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SUMMARY 
 
 
This descriptive study included all the ovarian tumors received in 
the Department of Pathology, Coimbatore Medical College in three 
years, from March 2007 to April 2010. A total 301 cases were studied 
and analyzed in the present study.  
1. Ovarian tumors were found to be more common in reproductive      
age group. The premenopausal age group was more frequently 
affected      than post menopausal age group. 
2. Even though the total number of nulliparous patients and patients with 
low parity was low, the incidence of malignant ovarian tumors was 
higher in them. 
3. The incidence of benign tumors was found to be much higher than      
that of borderline and malignant tumors. 
4. Surface epithelial ovarian tumors were the most common category    
followed by germ cell tumors. Metastatic tumors were least  common. 
5. Most of the tumors were cystic in consistency with complex or solid 
architecture being less common, which could be explained by the 
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higher incidence of benign surface epithelial tumors having cystic 
morphology. 
7.    The tumors ranged in size from 3 to 31 cms. Most of the tumors were 
less than 20 cms in size. 
8.    Incidence of bilateral tumors was less than unilateral tumors. But in 
bilateral tumors there was a higher incidence of malignancy, 
whether primary or metastatic. 
9.  Abdominal pain was the most common symptom followed by mass  
per abdomen. 
10.  Benign serous cystadenoma was the most common ovarian tumor      
followed by benign mucinous cystadenoma. No case of  transitional 
cell tumor was recorded. 
11. Increased incidence of malignancy was noted with age more than       
50 years, postmenopausal age group, solid and complex tumor       
morphology, nulliparity or low parity and bilaterality of tumors.     
All these risk factors were found to be statistically significant. Early      
menarche and tumor diameter did not correlate with increased risk      
of malignancy.   
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                                    CONCLUSION 
 
 
Surface epithelial ovarian tumors was the most common category 
of ovarian tumors followed by germ cell tumors, sex cord stromal tumors 
and metastatic tumors in decreasing order of frequency. Incidence of 
benign tumors was much higher than malignant tumors with benign 
serous cystadenoma being the most common benign tumor and serous 
cystadenocarcinoma being the most common malignant tumor. 
Reproductive age group showed higher incidence of ovarian tumors 
whereas there was increasing incidence of malignancy with increasing 
age group. Exception to this was the higher incidence of malignant germ 
cell tumors in adolescent age group. Although nulliparity and low parity 
showed higher risk of malignancy, early menarche did not reveal any 
significant increase in malignancy. Pain in abdomen was the most 
common symptom whereas ascites was more commonly seen with 
malignant tumors. Menstrual complaints were observed more commonly 
with tumors with functional stroma with possible role of hormonal 
influence. Benign tumors showed cystic morphology and there was 
significant increase in incidence of malignancy in tumors with complex 
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or solid morphology. Thus age more than 50 years, post menopausal age 
group, solid and complex tumor morphology, presence of ascites, 
nulliparity or low parity and bilaterality of tumors significant increased 
incidence of malignancy and thus these parameters can be used to predict 
the risk of malignancy in ovarian tumors. 
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LIMITATIONS OF THE STUDY: 
 
This is a descriptive study. A longitudinal study with follow up of 
patients will definitely of great value in predicting usefulness of the risk 
factors for malignancy evaluated in this study. In the present study, 
limited parameters were studied where as a study including additional 
parameters such as family history of ovarian carcinoma, obesity, tumor 
markers, socioeconomic status, age at first childbirth, use of oral 
contraceptive pills or other hormonal intake will be of greater value. 
 
 
FUTURE SCOPE OF PRESENT STUDY: 
 
 
This study is of public health importance as it evaluates the 
incidence of various histopathological patterns, relative incidence of 
benign and malignant ovarian tumors and the risk factors associated with 
increased risk of malignancy in our population. This study may be 
helpful to clinicians as it gives them parameters to predict the relative 
risk of malignancy and plan the treatment protocol.  
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No HPE No IP No Age        Laterality Size Diagnosis
0 1 2 3 ≥4 <11 11to12 12to13 13to14 14to15 >15 pre post U/L B/L pain mass ascites menstrua urinary asympto Cystic solid complex
1 G136/09 208 35          +       + +            +     + 7x6x5         + 12
2 G408/09 9869 20          +        + +           +      + 6.5X6X4       + 5
3 G427/09 9138 46          +       +              +            +      + 5X5X2.5      + 12
4 G632/09 10692 30       +      + +  +  + 17X14X5  + 5
5 G706/09 18166 23  +  +  +  +  + 5X3X3  + 1
6 G737/09 12433 23  +    + +  +  + 14X13X8  + 3
7 G739/09 9319 58       +       +       +       +       + 24X20X13       +       6
8 G760/09 14581 52       +       +       +       +       + 5X3X3       + 1
9 G816/09 20626 17       +       + +       +       + 10X7X6       + 2
10 G820/09 15135 38       +       + +       +       + 5X4X2.5       + 1
11 G879/09 20382 46       +       +       +       +       + 9X7X2.5       + 1
12 G914/09 22547 27       +       + +       +       + 19X15X10       + 1
13 G958/09 21200 45       +       +       +       +       + 20X15X7       + 1
14 G959/09 22302 48       +       +       +       +       + 8.5X7X3       + 10
15 G964/09 18007 38       +       +  +       +       + 5X3.5X2       + 1
16 G1009/09 19583 60       +       +       +       +       + 12X10X7       + 9
17 G1083/09 25185 42       +       +  +       +       + 18X13X6       + 5
18 G1085/09 21801 42       +       +       +       +       + 8X7.5X5       + 5
19 G1169/09 28992 32       +       +       +       +       + 7X5X2.5       + 5
20 G1190/09 28400 40       +       +       +       +       + 6X4X4       + 18
21 G1207/09 27874 40       +       +        +       +       + 6X5X2.5       + 12
22 G1236/09 28283 38       +       +       +       +       + 20X15X6       + 5
23 G1272/09 27255 60       +       +       +       +       + 7X6X2       + 1
24 G1444/09 24632 40       +       +       +       +       + 13X11X8       + 10
25 G1551/09 36041 34       +       +       +       +       + 9X8X3       + 1
26 G1675/09 28413 60       +       +       +       +       + 13X12X7       + 4
27 G1772/09 40504 45       +       +       +       +       + 12X11X6.5       + 5
28 G1823/09 37921 60       +       +       +       +       + 25X24X15       + 7
29 G1833/09 43422 21       +       +       +       +       + 7X5.5X4       + 1
30 G1835/09 40587 27       +       +       +       +       + 30X25X15       + 1
31 G1859/09 45533 24       +       +       +       +       + 5X5X4       + 1
32 G1885/09 45085 42       +       +       +       +       + 10X8X6       + 1
33 G1886/09 45922 35       +       +       +       +       + 10X7.5X5       + 1
34 G1929/09 41783 63       +      +       +       +       + 15X13X5       + 11
35 G1956/09 42136 60       +       +       +       +       + 6X5X4       + 12
36 G2045/09 48863 68       +       +       +       +       + 21X17X7       + 21
37 G2048/09 41809 20     +       +       +       +       + 27X18X10       + 14
38 G2052/09 48856 50       +       +       +       +       + 9X5X4       + 4
39 G2055/09 48420 58       +       +       +       +       + 8X7X5       + 11
40 G2086/09 43242 68       +       +       +       +       + 5X4X3       + 4
41 G2123/09 44907 57        +        +            +          +          + 25X22X7          + 2
42 G2205/09 51388 55        +        +          +          +          + 17X15X10          + 5
43 G2212/09 52251 70        +        +          +          +          + 5X4X3          + 9
44 G2248/09 52598 50        +        +          +          +          + 14X14X13          + 10
45 G2265/09 56505 21        +        +          +          +          + 8X8X7          + 1
46 G2266/09 54748 26        +        +          +          +          + 7X6X3        + 12
47 G2267/09 53408 29        +        +          +          +          + 6X5X4        + 7
48 G2317/09 56347 46        +        +          +          +          + 18X15X6        + 7
49 G2391/09 58893 26        +        +          +          +          + 24X18X11        + 7
                               Parity                                            Age at menarche                                                 Menstrual status                  Gross              
ANNEXURE VI -  MASTER CHART
                             Complaints                                       
50 G2491/09 59446 28        +        +          +          +          + 11X9X7        + 19
51 G2501/09 62294 60        +        +        +        +        + 6X5X4        + 4
52 G2548/09 63913 45        +        +        +        +        + 6.5X5X2        + 18
53 G2558/09 63238 22        +        +        +        +          + 12X9X4        + 1
54 G2664/09 66663 28        +        +        +        +        + 6X4X3        + 12
55 G2676/09 58115 50        +        +        +        +        + 20X15X6        + 8
56 G2738/09 69686 38        +        +        +        +        + 9X6X4        + 1
57 G2786/09 70170 34        +        +        +        +        + 15X12X10        + 5
58 G2796/09 62571 38        +        +        +        +        + 10X8X4        + 1
59 G2797/09 69615 45        +        +        +        +        + 10X8X3        + 7
60 G42/09 67787 43        +        +        +        +        + 4X3X2        + 5
61 E40/09 4335 40        +       +       +       +        + 12X11X4       + 8
62 E68/09 4823 60        +       +       +       +       + 17X15X11       + 4
63 E366/09 5063 27        +       +       +       +       + 13X10X7       + 12
64 E386/09 4564 32        +       +       +       +       + 17X16X12       + 5
65 E471/09 5412 64        +       +       +       +        +       12X12X5       + 1
66 E535/09 6984 43        +       +       +       +       + 8X6X3       + 1
67 E602/09 7944 45        +       +       +       +       + 15X14X6       + 5
68 E686/09 8901 40        +       +       +       +       + 13X9X7       + 1
69 E723/09 9192 65        +       +       +       +       + 16X11X7       + 5
70 E826/09 11338 48        +       +       +       +       + 5X4X3.5       + 12
71 P7/09 3657 55        +       +           +       +       + 3X2X1.5       + 10
72 P93/09 10888 28        +       +           +       +       + 12X8X6       + 1
73 P117/09 13476 45        +       +           +       +       + 12X9X6       + 12
74 P168/09 42071 40        +       +           +       +       + 6X5X4       + 5
75 P199/09 8715 50        +       +           +       +       + 27X22X14       + 5
76 P210/09 22005 30        +       +           +       +       + 5X5X5       + 1
77 P215/09 20948 18        +       +           +       +       + 11X9X4       + 1
78 PH139/09 20918 40        +       +           +       +       + 7X5X4       + 5
79 326/09 5733 18        +       +           +       +       + 21X15X11       + 14
80 PH1/09 4998 22        +       +           +       +       + 7X7X6       + 5
81 PH52/09 8001 44        +       +           +       +       + 15X12X7.5       + 1
82 PH61/09 10614 20        +       +           +       +       + 9X8X6       + 15
83 PH75/09 12695 24        +       +           +       +       + 9X7X6       + 1
84 PH78/09 12455 28        +       +           +       +       + 11X11X10       + 1
85 PH80/09 13312 32        +       +       +       +       + 12X9X8       + 5
86 PH105/09 37678 45        +       +       +       +       + 7X4X4       + 1
87 PH106/09 16220 29        +       +       +       +       + 7X6X4       + 1
88 PH123/09 16092 45        +       +       +       +       + 14X11X6       + 1
89 PH130/09 16724 40        +       +       +       +       + 5X4X4       + 1
90 G7/08 70835 56       +       +       +       +       + 12X9X8       + 8
91 G10/08 72356 55       +       +       +       +       + 9X6X3       + 4
92 G41/08 75252 40       +       +       +       +       + 11X8X8       + 5
93 G58/08 443 29       +       +       +       +       + 14X11X11       + 5
94 G59/08 73615 37       +       +       +       +       + 9X6X4       + 12
95 G119/08 1101 55       +       +       +       +       + 15X10X8       + 8
96 G153/08 922 48       +       +       +       +       + 13X10X6       + 7
97 G181/08 2876 47       +       +       +       +       + 15X14X7       + 4
98 G237/08 3136 35       +       +       +       +       + 6X4X4       + 1
99 G265/08 5187 64       +       +       +       +       + 22X15X10       + 8
100 G315/08 4957 70       +       +       +       +       + 8X5X3       + 1
101 G362/08 6946 37       +       +       +       +       + 17X12X10       + 5
102 G431/08 9198 45       +       +       +       +       + 20X12X10       + 5
103 G446/08 7406 45       +       +       +       +       + 17X15X10       + 1
104 G533/08 8201 45       +       +       +       +       + 7X6X4       + 4
105 G594/08 12932 60       +       +       +       +       + 10X10X9       + 5
106 G695/08 16718 30       +       +       +       +       + 17X15X8       + 7
107 G754/08 16702 48       +       +       +       +       + 12X11X10       + 5
108 G793/08 18699 38       +       +       +       +       + 17X15X11       + 8
109 G821/08 19841 38       +       +       +       +       + 7X6X3       + 12
110 G872/08 21667 45       +       +       +       +       + 15X9X8       + 5
111 G980/08 12673 49       +       +       +       +       + 12X10X9       + 5
112 G1017/08 27089 55       +       +       +       +       + 11X10X9       + 1
113 G1030/08 26153 47       +       +       +       +       + 7X4X3       + 4
114 G1090/08 27590 28       +       +       +       +       + 12X11X10       + 8
115 G1153/08 25630 19       +       +       +       +       + 25X20X17      + 19
116 G1253/08 31829 24       +       +       +       +       + 14X12X10      + 12
117 G1254/08 30407 76       +       +       +       +       + 5X4X3      + 4
118 G1294/08 31813 43       +       +       +       +       + 8X7X7      + 1
119 G1296/08 28054 47       +       +       +       +       + 9X8X8      + 10
120 G1321/08 31439 60       +       +       +       +       + 16X15X15      + 1
121 G1328/08 34992 17       +       +       +       +       + 20X20X18      + 5
122 G1420/08 36068 55       +       +       +       +       + 14X12X10      + 1
123 G1448/08 35548 62       +       +       +       +       + 13X12X10      + 1
124 G1250/08 35026 40       +       +       +       +       + 23X15X14      + 5
125 G1478/08 36398 23       +       +       +       +       + 17X15X14       + 13
126 G1497/08 36376 45       +       +       +       +       + 15X12X10       + 21
127 G1514/08 36580 45       +       +       +       +       + 11X10X9       + 1
128 G1515/08 36569 70       +       +       +       +       + 12X10X9       + 8
129 G1527/08 39120 32       +       +       +       +       + 18X17X15       + 1
130 G1585/08 39114 43       +       +       +       +       + 9X8X7       + 5
131 G1632/08 41329 21       +       +       +       +       + 12X11X10       + 18
132 G1690/08 36586 60       +       +       +       +       + 17X16X11       + 7
133 G1805/08 38092 46       +       +       +       +       + 22X20X19       + 5
134 G1826/08 45980 41       +       +       +       +       + 13X6X4       + 18
135 G1846/08 45242 38       +       +       +       +       + 11X10X7       + 12
136 G1883/08 46271 50       +       +       +       +       + 9X7X6       + 5
137 G1928/08 48067 35       +       +       +       +       + 15X14X8       + 20
138 G1948/08 50767 45       +       +       +       +       + 17X12X8       + 8
139 G1973/08 50858 70       +       +       +       +       + 22X20X17       + 1
140 G2001/08 51537 42       +       +       +       +       + 6X5X3       + 10
141 G2085/08 52396 33       +       +       +       +       + 17X15X14       + 8
142 G2153/08 56505 43       +       +       +       +       + 5X3X2       + 4
143 G2196/08 56519 40       +       +       +       +       + 23X17X15       + 8
144 G2204/08 54134 58       +       +       +       +       + 20X15X10       + 1
145 G2319/08 58922 23       +       +       +       +       + 8X8X6       + 12
146 G2356/08 56229 15       +       +       +       +       + 15X11X10       + 5
147 G2358/08 59699 30       +       +       +       +       + 18X12X11       + 5
148 G2394/08 55005 50       +       +       +       +       + 17X12X10       + 18
149 G2520/08 63279 55       +       +       +       +       + 20X19X15       + 12
150 G2530/08 60454 28       +       +       +       +       + 12X9X6       + 21
151 G2544/08 64358 20       +       +       +       +       + 13X11X10       + 15
152 G2589/08 64124 55       +       +       +       +       + 18X16X15       + 8
153 G2590/08 66177 27       +       +       +       +       + 3X2X2       + 5
154 G2637/08 65850 36       +       +       +       +       + 12X10X9       + 2
155 G2638/08 66019 19       +       +       +       +       + 15X14X9       + 13
156 G2679/08 67419 22       +       +       +       +       + 12X10X8       + 1
157 G2756/08 69854 22       +       +       +       +       + 14X11X9       + 5
158 E177/08 1000 29       +       +       +       +       + 13X12X9       + 5
159 E206/08 1314 47       +       +       +       +       + 10X8X5       + 1
160 E233/08 1427 35       +       +       +       +       + 10X10X9       + 3
161 E237/08 1507 43       +       +       +       +       + 9X4X3       + 1
162 E280/08 2235 24       +       +       +       +       + 14X11X10       + 5
163 E298/08 2413 30       +       +       +       +       + 6X4X4       + 1
164 E300/08 2114 59       +       +       +       +       + 5X5X3       + 18
165 E399/08 1376 25       +       +       +       +       + 6X6X4       + 1
166 E402/08 2922 44       +       +       +       +       + 18X16X10       + 1
167 E434/08 3911 43       +       +       +       +       + 22X19X11       + 5
168 E543/08 5173 45       +       +       +       +       + 14X12X10       + 5
169 E800/08 3260 28       +       +       +       +       + 12X10X9       + 7
170 E819/08 7916 49       +       +       +       +       + 10X8X7       + 1
171 E941/08 10303 28       +       +       +       +       + 14X11X6       + 12
172 E943/08 9629 58       +       +       +       +       + 14X12X10       + 16
173 E1024/08 10735 34       +       +       +       +       + 9X6X5       + 8
174 E1111/08 11823 25       +       +       +       +       + 5X4X3       + 12
175 PH9/08 981 58       +       +       +       +       + 15X12X10       + 5
176 PH23/08 1482 23       +       +       +       +       + 6X6X6       + 1
177 PH35/08 5041 27       +       +       +       +       + 19X16X8       + 5
178 PH46/08 7711 34       +       +       +       +       + 8X7X6       + 1
179 PH48/08 6754 33       +       +       +       +       + 23X18X12       + 1
180 PH53/08 7318 40       +       +       +       +       + 10X8X8       + 1
181 PH61/08 8258 51       +       +       +       +       + 10X9X9       + 1
182 PH63/08 9247 43       +       +       +       +       + 6X6X6       + 1
183 PH99/08 15420 28       +       +       +       +       + 14X13X12       + 1
184 PH120/08 23147 38       +       +       +       +       + 14X8X6       + 1
185 PH124/08 24238 30       +       +       +       +       + 12X12X12       + 2
186 PH137/08 24290 48       +       +       +       +       + 5X4X3       + 1
187 P5/08 27055 29       +       +       +       +       + 8X7X6       + 1
188 P88/08 303582 28       +       +       +       +       + 13X10X7       + 17
189 P151/08 15192 63       +       +       +       +       + 20X20X20       + 10
190 G36/07 60905 24       +       +       +       +       + 15X8X7       + 1
191 G42/07 66194 25       +       +       +       +       + 24X15X8       + 21
192 G43/07 486 44       +       +       +       +       + 7X6X4.5       + 4
193 G79/07 1359 23       +       +       +       +       + 5X3X2       + 1
194 G114/07 56129 45       +       +       +       +       + 10X8X4       + 4
195 G119/07 65696 74       +       +       +       +       + 6X5X4       + 1
196 G157/07 1705 60       +       +       +       +       + 10X10X7       + 1
197 G213/07 2729 60       +       +       +       +       + 17X13X8       + 1
198 G314/07 1545 43       +       +       +       +       + 6X3X2       + 4
199 G330/07 3315 50       +       +       +       +       + 20X16X10       + 5
200 G332/07 5906 28       +       +       +       +       + 12X8X6       + 1
201 G402/07 6099 45       +       +       +       +       + 11X6X4       + 1
201 G439/07 30950 35       +       +       +       +       + 20X16X12       + 5
203 G452/07 5006 50       +       +       +       +             + 9X7X5       + 10
204 G465/07 9546 40       +       +       +       +       + 7X6X5       + 12
205 G471/07 10348 70       +       +       +       +       + 14X14X12       + 10
206 G660/07 10230 40       +       +       +       +       + 6X4X3       + 15
207 G667/07 14142 57       +       +       +       +       + 16X10X9       + 4
208 G673/07 12385 24       +       +       +       +       + 16X12X8       + 5
209 G743/07 14228 50       +       +       +       +       + 9X9X5       + 4
210 G766/07 116 53       +       +       +       +       + 16X14X9       + 10
211 G816/07 15171 35       +       +       +       +       + 12X8X5       + 5
212 G842/07 16323 37       +       +       +       +       + 10X8X7       + 1
213 G922/07 19872 26       +       +       +       +       + 15X15X15       + 1
214 G981/07 21191 40       +       +       +       +       + 9X7X4       + 4
215 G1060/07 19031 65       +       +       +       +       + 11X10X5       + 6
216 G1064/07 21713 26       +       +       +       +       + 10X7X5       + 5
217 G1065/07 157392 60       +       +       +       +       + 13X10X7       + 7
218 G1073/07 22882 25       +       +       +       +       + 10X8X6       + 1
219 G1074/07 21922 40       +       +       +       +       + 9X8X4       + 1
220 G1099/07 21177 55       +       +       +       +       + 5X5X5       + 18
221 G1107/07 23287 36       +       +       +       +       + 15X10X9       + 15
222 G1188/07 20064 60       +       +       +       +       + 15X10X9       + 1
223 G1198/07 24658 24       +       +       +       +       + 9X7X6       + 1
224 G1236/07 25041 40       +       +       +       +       + 7X7X7       + 1
225 G1285/07 25664 35       +       +       +       +       + 4X3X2       + 1
226 G1376/07 28067 35       +       +       +       +       + 18X10X9       + 15
227 G1379/07 28442 21       +       +       +       +       + 10X10X10       + 1
228 G1384/07 26322 46       +       +       +       +       + 20X10X4       + 1
229 G1423/07 28587 34       +       +       +       +       + 8X4X3       + 1
230 G1430/07 30154 55       +       +       +       +       + 8X7X7       + 1
231 G1432/07 28798 50       +       +       +       +       + 6X4X3       + 1
232 G1488/07 27500 40       +       +       +       +       + 20X15X10       + 5
233 G1512/07 40501 40       +       +       +       +       + 15X11X9       + 4
234 G1514/07 40976 26       +       +       +       +       + 10X10X10       + 1
235 G1523/07 40406 35       +       +       +       +       + 7X6X4       + 1
236 G1570/07 40032 40       +       +       +       +       + 10X7X4       + 5
237 G1718/07 44759 37       +       +       +       +       + 6X4X4       + 12
238 G1721/07 44374 38       +       +       +       +       + 20X20X19       + 5
239 G1761/07 22228 60       +       +       +       +       + 6X4X3       + 1
240 G1780/07 43165 60       +       +       +       +       + 25X24X18       + 5
241 G1806/07 47310 34       +       +       +       +       + 10X8X4       + 5
242 G1807/07 44303 45       +       +       +       +       + 14X14X8       + 15
243 G1946/07 49323 38       +       +       +       +       + 7X6X3       + 5
244 G2002/07 50316 45       +       +       +       +       + 11X10X6       + 15
245 G2109/07 50685 35       +       +       +       +       + 13X11X10       + 5
246 G2112/07 52989 35       +       +       +       +       + 16X11X10       + 5
247 G2113/07 50399 53       +       +       +       +       + 19X14X12       + 5
248 G2128/07 53911 28       +       +       +       +       + 13X9X8       + 12
249 G2133/07 52216 52       +       +       +       +       + 15X13X12       + 5
250 G2190/07 52572 58       +       +       +       +       + 20X19X9       + 5
251 G2222/07 56615 14       +       +       +       +       + 17X14X10       + 13
252 G2297/07 55577 45       +       +       +       +       + 4X3X2       + 10
253 G2317/07 4951 65       +       +       +       +       + 20X13X12       + 17
254 G2342/07 60328 36       +       +       +       +       + 21X18X16       + 1
255 G2345/07 60120 40       +       +       +       +       + 15X10X9       + 1
256 G2427/07 60198 28       +       +       +       +       + 8X5X4       + 5
257 G2443/07 49488 45       +       +       +       +       + 28X25X14       + 7
258 G2530/0 61691 45       +       +       +       +       + 10X9X7       + 8
259 G2569/07 63513 40       +       +       +       +       + 10X8X4       + 10
260 G2871/07 70653 27       +       +       +       +       + 10X8X6       + 12
261 G2917/07 71742 33       +       +       +       +       + 9X7X2.5       + 1
262 G2925/07 73740 25       +       +       +       +       + 16X12X7       + 8
263 G2962/07 70861 55       +       +       +       +       + 9X7X4       + 4
264 G2991/07 75089 28       +       +       +       +       + 6X4X3       + 1
265 E58/07 13880 42       +       +       +       +       + 13X13X13       + 1
266 E208/07 1785 60       +       +       +       +             + 19X17X13       + 5
267 E303/07 2912 47       +       +       +       +       + 26X20X12       + 1
268 E838/07 8237 32       +       +       +       +       + 18X16X13       + 1
269 E911/07 9974 62       +       +       +       +             + 10X9X7       + 18
270 PH4/07 31659 33       +       +       +       +       + 7X5X3       + 1
271 PH21/07 39870 30       +       +       +       +       + 25X25X20       + 1
272 PH23/07 4660 30       +       +       +       +       + 15X10X8       + 5
273 PH51/07 11579 26       +       +       +       +       + 8X7X7       + 1
274 PH53/07 11015 25       +       +       +       +       + 30X20X20       + 5
275 PH59/07 13315 21       +       +       +       +       + 12X10X9       + 1
276 PH108/07 18339 26       +       +       +       +       + 9X7X7       + 1
277 PH121/07 21398 40       +       +       +       +       + 9X6X5       + 1
278 PH125/07 22903 16       +       +       +       +       + 8X6X3       + 1
279 P3/07 803656 32       +       +       +       +       + 6X5X5       + 1
280 P33/07 19134 40       +       +       +       +       + 5X3X2       + 15
281 P60/07 804692 21       +       +       +       +       + 6X5X4       + 1
282 P85/07 803766 30       +       +       +       +       + 30X15X10       + 1
283 P163/07 806251 28       +       +       +       +       + 9X6X5       + 1
284 P193/07 806881 27       +       +       +       +       + 7X4X2       + 12
285 G38/10 73487 38       +       +       +       +       + 10X9X8       + 12
286 G192/10 3726 43       +       +       +       +       + 9X8X7       + 1
287 G286/10 5304 35       +       +       +       +       + 11X9X8       + 12
288 G302/10 73465 38       +       +       +       +       + 10X9X9       + 1
289 G319/10 1115 40       +       +       +       +       + 11X8X7       + 12
290 G324/10 5126 30       +       +       +       +       + 18X15X10       + 1
291 G395/10 10611 27       +       +       +       +       + 9X7X6       + 5
292 G397/10 3778 30       +       +       +       +       + 13X12X10       + 4
293 G490/10 7106 55       +       +       +       +       + 13X12X11       + 1
294 G507/10 10661 53       +       +       +       +       +       + 4X4X3.5       + 11
295 P3/10 27920 60       +       +       +       + 27X17X10       + 8
296 P5/10 27984 25       +       +       +       +       + 14X14X10       + 5
297 PH12/10 2170 30       +       +       +       +       + 7X5X4       + 12
298 PH15/10 2481 27       +       +       +       +       + 13X12X11       + 1
299 PH33/10 4701 22       +       +       +       +       + 21X17X12       + 13
300 E12/10 12061 37       +       +       +       +       + 12X12X11       + 1
301 E74/10 1021 38       +       +       +       +       + 10X8X7       + 5
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ANNEXURE – I 
PROFORMA 
 
• DEMOGRAPHIC DETAILS : 
                    Name 
   Age 
• IDENTIFICATION DETAILS : 
                     IP No. 
                     HPE No. 
• MODE OF PRESENTATION : 
                     Abdominal pain 
                     Mass per abdomen       
       Ascites 
      Menstrual complaints 
     Urinary complaints 
            Asymptomatic 
• PAST HISTORY :   
• FAMILY HISTORY: 
• MENSTRUAL HISTORY: 
                Age at menarche  
                Age at menopause  
• PARITY : 
• GROSS DETAILS : 
            Laterality – Unilateral / Bilateral 
            Size in cms. 
   External surface 
   Cut surface – Cystic / Solid / Complex 
            Contents of the cyst – Serous / Mucinous / Pultaceous 
           Other relevant details 
• MICROSCOPIC DETAILS : 
• HISTOPATHOLOGICAL DIAGNOSIS : 
 
 
                                 
 
 
 
                          
 
                          
ANNEXURE – II 
 
I. HAEMATOXYLIN AND EOSIN STAINING 
 
Fixation – 10% Formalin 
 
Technique – Paraffin section cut at 6 microns 
 
SOLUTION PREPARATION: 
Haematoxylin         -   10 gram.  
 
Absolute alcohol        - 100 ml       Dissolve with light heat  
 
  Aluminum Potassium sulphate 200 gram dissolved in warm 2 liters 
of distilled water. Both are mixed and boiled: 5 gms of mercuric oxide is 
added while boiling and cooled after two minutes. Prior to use, 3 ml of 
acetic acid for 100 ml of hematoxylin is added.  
1% ACID ALCOHOL 
 
70% alcohol                -   990 ml. 
 
Concentrated HCI       -   10 ml. 
 
EOSIN 
 
Eosin    -  10 gram   
   Dissolved 
D.H2O -   100 ml.  
 
Phloxine ‘B’  - 100 mg 
   Dissolved 
D.H2O           -  20 ml 
  Both are mixed and 780 ml of 90% alcohol is added. 4 ml of glacial 
acetic acid and saturated Lithium carbonate are added.  
PROCEDURE: 
 
1.  The slide is kept in xylene  for 15 minutes. 
2.  It is washed in graded alcohol absolute 90% : 80% each 2 dips 
3.  Slide is washed in water for 5 minutes. 
4.  Stained in haematoxylin for  5 minutes. 
5.  It is washed in water for 5 minutes. 
6. Differentiated in 1% acid alcohol 2 dips 
7. Washed in water for 2 minutes. 
8. Twice dipped in Lithium carborate for blueing 
9. Washed in water for 10 minutes 
10.  Dipped in 80% alcohol 
11.  Stained with eosin for 5 minutes. 
12. Dehydrated in graded alcohol 80%, 90% then absolute alcohol  
13. Cleared in xylene. 
14.  Mounted in D.P.X. 
RESULTS: 
 Nuclei   - Blue       Cytoplasm   - Pink                                
ANNEXURE – III 
 
PERIODIC ACID SCHIFFS REAGENT STAIN (PAS) 
 
Fixation  - 10% Formalin, Alcohol, Buffered Formalin. 
 
Technique  - Paraffin Section cut at 6 microns 
 
SOLUTION PREPARATION  
 
1% Periodic Acid 
 
Periodic Acid - 1 gram 
 
Distilled water - 100 cc 
 
SCHIFFS REAGENT 
 
 In 100ml of warm distilled water 5 gram of Basic fuschin is added 
and allowed to boil. It is then cooled and 10 gram of potassium 
metabisulphite and 50ml of 1 Normal HCL 50ml are added and kept in 
dark place over night (24 hours) Then  25 gram of charcoal powder is 
added, shaken and kept  in dark place for 2 hours. It is filtered and stored 
in fridge. 
1. NORMAL HCL   
            HCL -  8.35ml 
            Distilled water -  91.65 ml 
 
 
PROCEDURE: 
1. The slide is deparaffinised in  15 ml of xylene. 
2. Washed in Graded alcohol ab.90%,80% each 2 dips. 
3. Washed in water for 5 minutes. 
4. Placed in 1% periodic acid 5 minutes. 
5. Washed in water for 5 minutes.   
6. Placed in Schiffs reagent 15 minutes. 
7. Washed in water for 10 minutes. 
8. Stained in Haematoxylin for 3 minutes. 
9. Then washed in water for 2 minutes. 
10. Differentiated in 1% acid alcohol 3 dips. 
11. Washed in water for 2 minutes. 
12. Lithium carbonate 1 dip. 
13. Washed in water. 
14. Dehydrated (80%, 90%, Alcohol) cleared and mounted. 
RESULT: 
Glycogen, mucin, reticulin, Basement membranes, amyloid and other           
elements may show a positive reaction – rose to purplish red  
Nuclei – Blue     Fungi   - Red 
ANNEXURE – IV 
 
RETICULIN STAIN 
 
Fixation  - 10% Formalin, Alcohol, Buffered Formalin. 
Technique  - Paraffin Section cut at 6 microns 
SOLUTIONS PREPARATION: 
1. AMMONICAL SILVER SOLUTION: 
  Take 10 ml of 10% Silver nitrate and add 2.5 ml 10% aqueous 
solution of KOH. Mix and then add 28% ammonia drop by drop until     
precipitate is completely dissolved by shaking. Add an equal volume of 
distilled water. 
 
2.  0.5 % KMnO4   
  (0.5 gm KMnO4  + distilled water 100ml) 
3.  2 % POTASSIUM METABISULPHITE  
      ( 2gm potassium metabisulphite + distilled water 100ml) 
4.  2 % FERRIC AMMONIUM SULPHATE  
        ( 2gm ferric ammonium  sulphate + distilled water 100ml) 
5.  20% FORMALIN  
     (Formaldehyde 20 ml + distilled water 80ml) 
6. 0.2 % GOLD CHLORIDE  
    ( gold chloride 1% 10 ml + distilled water 40 ml) 
7.  2%  SODIUM THIOSULPHATE 
    ( 2gm Sodium thiosulphate + distilled water 100ml) 
 
PROCEDURE: 
1. The slide is deparaffinised in  15 ml of xylene. 
2.Washed in Graded alcohol ab.90%,80% each 2 dips 
3.Washed in water for 5 minutes  
4. Oxidize in KMnO4 for 1 minute. 
5. Wash in tap water for 2 minutes. 
6. Differentiate in potassium metabisulphite for 1 minute. 
7. Wash in tap water for 2 minutes. 
8. Sensitize in ferric ammonium  sulphate for 1 minute. 
9. Wash in tap water for 2 minutes. 
10. 2 changes of distilled water. 
11. Impregnate with silver solution for 1 minute. 
12. Rinse in distilled water for 20 seconds. 
13. Reduce in formalin solution for 3 minutes. 
14. Wash in tap water for 2 minutes. 
15. Tone in gold chloride for 10 minutes. 
16. Rinse in distilled water. 
17. Reduce in potassium metabisulphite for 1 minute. 
18. Fix in potassium thiosulphate for 1 minute. 
19. Wash in tap water for 2 minutes. 
20. Dehydrated (80%, 90%, Alcohol) cleared and mounted. 
 
RESULT: 
 
Reticulin fibers: Black 
 
Background: colorless 
 
 
 
 
 
 
 
 
 
 
 
ANNEXURE – V 
 
IMMUNOHISTOCHEMISTRY  PROCEDURE 
 
1. Sections are cut at 4µm, taken in coated slides and incubated at 58o c 
for overnight. 
2. Dewax the section in xylene for about 30 minutes. 
3. Immerse in absolute alcohol for 2 minutes x 2 changes. 
4. Wash in tap water for about 10 minutes. 
5. Rinse in distilled water for about 5 minutes. 
6. Antigen retrieval was done in microwave oven with appropriate 
buffer solution in appropriate temperature for about 20 to 25 
minutes. 
7. Cool it to room temperature. 
8. Rinse in distilled water for about 5 minutes. 
9. Wash in wash buffer ( TBS) - 5 minutes x 2 changes. 
10. Apply peroxidase block for about 10 minutes. 
11. Wash in wash buffer 5 minutes x 2 changes. 
12. Apply power block – 10 minutes. 
13. Don't wash, drain and apply primary antibody for about 1 hr in  a 
moisture chamber. 
14. Wash in wash buffer 5 minutes x 2 changes. 
15. Apply Super enhancer – 30 minutes. 
16. Wash in wash buffer – 5 minutes x 2 changes. 
17. Apply S.S.Label poly HRP reagent for about 30 minutes. 
18. Wash in wash buffer 5 minutes x 2 changes. 
19. Apply chromogen that contains DAB and substrate buffer to 5 to 8 
minutes. 
20. Wash in wash buffer 5 minutes x 2 changes. 
21. Wash in tap water – 5 minutes. 
22. Counter stain with haematoxylin..30 seconds. 
23. Wash in tap water. 
24. Air dry, clean in xylene and mount with DPX mountant.  
 
RESULTS: 
The development of brown color is interpreted as positive and 
scoring done using Quick score method. 
 
